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Abstract
Recently several studies with low-dose bupivacaine for ambulatory knee arthros-
copy have been conducted with varying failure rates and time to home-readiness.
We tested the hypothesis that selective spinal anaesthesia (SSA) with bupivacaine
(alone or together with fentanyl) is suited for outpatients undergoing knee ar-
throscopy.
Five prospective, randomized studies were conducted, consisting of 483 outpa-
tients undergoing knee arthroscopy. We tested the suitability of selective spinal
anaesthesia with low-dose hyperbaric bupivacaine alone (4 or 6 mg), or together
with fentanyl (3 mg + 10 µg) for knee arthroscopy. Since itching was common
after intrathecal fentanyl, one study was designed to answer the question “Does
intravenous ondansetron prevent pruritus induced by intrathecal fentanyl”. The
4th study was conducted to find out whether SSA can be achieved by injecting at
the L3/4 interspace, and whether a 5 degree head down tilt of the vertebral
column is needed to accomplish it. Finally, SSA was compared with desflurane-
maintained general anaesthesia (GA). The quality of SSA (the spread and the
recovery from sensory and motor block, and the side effects) was estimated in
each study. A strictly standardized technique, consisting of low-dose, low-flow,
low-volume, a lateral decubitus position for 10 min, with a carefully adjusted
position of the vertebral column (horizontal or a head down tilt of 5 degrees,
with the help of a spirit level) was used. Furthermore, the bevel of the needle was
directed towards the nerves involved through a G-27 Quincke needle. The time
spent in the postanaesthesia care unit and the time to home-readiness, as well as
side effects were evaluated after SSA and GA (maintained with desflurane).
An identical spread and recovery of the sensory block was seen when an identical
dose and technique were used. The head-down tilt of 5 degrees left the sacral
segments significantly more often intact compared to the horizontally positioned
patients, producing a clearly segmental block often seen during epidural block.
The failure rate was 2% and 3% after the 6 mg and 4 mg doses of bupivacaine, and
4% after 3 mg of bupivacaine + 10 µg of fentanyl when injected at L2/3 inter-
space with the vertebral column in a horizontal position. Four mg injected at the
L3/4 level together with a head down tilt resulted in a 2.5% failure rate, whereas
12% failed when the vertebral column was in a horizontal position.
The median time in the postanaesthesia care unit was 36 min after the com-
bination (3 mg of bupivacaine and fentanyl) and 55 min after 4 mg of bupi-
vacaine (P=0.005). Increasing the dose to 6 mg caused a further 30-min delay in
the PACU: 64 versus 94 min, after 4 mg and 6 mg of bupivacaine (P<0.001),
respectively. No difference in the PACU stay was seen after SSA (4 mg of bupi-
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vacaine) and GA (desflurane). Home-readiness was equal after SSA with 3 mg of
bupivacaine and fentanyl, with 4 mg of bupivacaine, and after GA maintained
with desflurane: 178 min, 186 min and 192 min, respectively. The 6 mg dose
prolonged the fulfilment of the home discharge criteria by 30 min when com-
pared with the 4 mg dose of spinal bupivacaine. After spinal anaesthesia, 5% of
the patients suffered from PDPH and 1% needed an epidural blood patch. 75% of
the patients receiving i.t. fentanyl developed pruritus, which was not preventable
with i.v. ondansetron. Pain, PONV and somnolence were more frequent after GA
than after SSA, whereas TNS occurred equally. None of the patients needed cath-
eterization to pass urine.
In conclusion, a standardized selective spinal anaesthesia technique with a 4 mg
dose of hyperbaric bupivacaine produced a highly predictable spread of spinal
block and home-readiness 3 hours after injection. Furthermore, a small change in
the dose, injection at a different vertebral site, and positioning the patient’s ver-
tebral column differently at the time of injection, altered the spread, the recovery
(and the reliability) of the spinal anaesthesia. Although home-readiness was sim-
ilar after selective spinal anaesthesia and desflurane-maintained general anaesthe-
sia, a higher number of side effects was associated with general anaesthesia. The
use of a 27-G Quincke spinal needle resulted in a high incidence of PDPH.
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Abbreviations
5-HT3 5-hydroxytryptamine-3
ASA American Society of Anesthesiologists
ASU Ambulatory surgery unit
BIS Bispectral Index of Electroencephalogram
BMI Body mass index
BPM Beats per minute
CI Confidence interval
CIA Confidence interval analysis
CO2 Carbon dioxide
CSF Cerebrospinal fluid
ECG Electrocardiogram
EO End of operation
EPI Epidural
FDA United States Food and Drug Administration
G Gauge
GA General anaesthesia
IA, i.a. Intra-articular
i.t. Intrathecal
i.v. Intravenous
L2/3, L3/4 Lumbar 2/3 or 3/4 interspace
LA Local anaesthetic
LMA Laryngeal mask airway
MAC Monitored anaesthesia care
MAP Mean arterial pressure
MRI Magnetic resonance imaging
N Number
N2O Nitrous oxide
NA Not applicable
NIBP Non-invasive blood pressure
NSAID Non-steroidal anti-inflammatory drug
OR Operating room
P Probability
PACU Postanaesthesia care unit
PDPH Postdural puncture headache
p.o. Per os
PONV Postoperative nausea and vomiting
RA Regional anaesthesia
SA Spinal anaesthesia
SAP Systolic arterial pressure
SD Standard deviation
SpO2 Peripheral oxygen saturation
SSA Selective spinal anaesthesia
TES Transcutaneous electrical stimulation
TNS Transient neurological symptoms
TOF Train of four
TRI Transient radicular irritation
VeAS Verbal analogue scale
VAS Visual analogue scale
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Introduction
A wide category of anaesthetic techniques can and have been used for outpatient
knee arthroscopy. The patients receiving regional anaesthesia are more alert and
suffer less from nausea and pain in the postanaesthesia care unit, compared with
patients undergoing general anaesthesia (Mulroy and McDonald 2003). On the
other hand, side effects like postdural puncture headache, transient neurological
symptomes, back pain and difficulties in voiding are sometimes associated with
neuraxial techniques (Mulroy and McDonald 2003). General anaesthesia can pro-
duce faster induction compared with regional techniques (not performed in an
induction area) (Wong et al. 2001). The use of modern general anaesthetics,
effective anti-emetic treatment and laryngeal mask airway have made the recovery
times after general anaesthesia and regional anaesthesia equal.
Selective spinal anaesthesia (SSA) is a practice of using minimal doses of in-
trathecal agents so that only the nerve roots supplying a specific area and only the
modalities that need to be anaesthetized are affected (Vaghadia 1998). Depend-
ing on the type of surgical procedure, the SSA can be either a bilateral or a unilat-
eral block. Extremely low doses have been applied in SSA for gynaecological
laparoscopies: 10 mg of lidocaine together with 10 µg of sufentanil provided a
significantly faster early stage recovery and ability to ambulate, compared with
general anaesthesia either with propofol (Stewart et al. 2001) or desflurane (Len-
nox et al. 2002b). Without a specific injection technique, the failure rate after
low-dose bupivacaine in knee arthroscopy patients has been as high as 24% de-
creasing to 0% when low-dose bupivacaine and fentanyl are combined (Ben-Dav-
id et al. 1997).
The purpose of the present series of studies was to produce reliable SSA with
bupivacaine for outpatients undergoing knee arthroscopy. The specific aim was
to compare the recovery times after SSA with different doses of bupivacaine (alone
or together with fentanyl) and after desflurane-maintained general anaesthesia
(GA), as well as to compare the time in the postanaesthesia care unit. Further-
more, the purpose was to evaluate the effects of a certain modification in the
spinal anaesthesia technique, such as injection site (L2/3 or L3/4) and the posi-
tion of the vertebral column (horizontal or tilted head down) on the spread of
spinal anaesthesia. Finally, the incidence of side effects after SSA and GA, and the
possibility of preventing intrathecal fentanyl-induced pruritus with intravenous
ondansetron were evaluated.
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Anaesthesia techniques used in outpatient knee
arthroscopy
Knee arthroscopy is a common procedure performed in an ambulatory setting.
Arthroscopic exploration of the knee may last only up to 10-15 min, whereas the
operations on meniscus, capsules and ligaments, on synovia of the knee or oper-
ation for osteochondritis last significantly longer. Whether muscle relaxation and
/ or tourniquet are required, depends mainly on the surgeon.
Regional anaesthesia
Peripheral blocks like femoral and sciatic nerve block have been used for knee
arthroscopy. The preparation time of combined sciatic-femoral block was slightly
longer than that of general anaesthesia, 16 versus 13 min (Casati et al. 2002).
After a combined sciatic-femoral block, a greater number of patients could by-
pass the postanaesthesia care unit (PACU) compared to general anaesthesia (GA)
with propofol-remifentanil, but readiness to discharge home was prolonged sig-
nificanly after peripheral block (Casati et al. 2002) (Table 1). In more recent
studies, the time to home-readiness was equal after GA (propofol + N2O), spinal
anaesthesia (SA) (bupivacaine 6 mg + fentanyl 15 µg) and psoas block (600 mg
mepivacaine) (Jankowski et al. 2003). Intra-articular (i.a.) local anaesthetic has
been used alone, or in combination with peripheral nerve blocks and monitored
anaesthesia care. The operation conditions and postoperative pain scores were
equal after an i.a. local anaesthetic with or without femoral nerve block in knee
arthroscopy patients (Goranson et al. 1997). In another study, 180 of 400 pa-
tients underwent elective knee arthroscopy with an i.a. local anaesthetic. Although
the authors concluded that elective knee arthroscopy is performable under i.a.
local anaesthesia in 92% of the patients, they found that in 16% (29/180) of the
patients, the technique was not considered optimal by the surgeon (Jacobson et
al. 2000). More often, i.a. drugs are used for postoperative pain (Kalso et al.
1997; Kalso et al. 2002).
Neuraxial anaesthesia (i.e. spinal or epidural) is popular for outpatient knee
arthroscopy. SA is easy to perform, rapid in onset (Mulroy 2002b) and cheap
(Dahl et al. 1997; Lennox et al. 2002a), whereas epidural anaesthesia (EPI) is
technically more difficult to perform. It is, however, possible to titrate the extent
of epidural anaesthesia through the catheter, thus decreasing the need for supple-
mentary medication, if the surgical procedure is prolonged (Mulroy 2002a). In a
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Table 1. A comparison of different anaesthesia techniques used in outpatients undergoing knee arthroscopy.
Prospective, randomized clinical trials.
Reference No. Anaesthetic Failure Fast- PACU Time to Ready to Comments/Other
technique (%) tracking time ambulate discharge results
(%) (min) (min) (min)
(Jankowski 60 Psoas block 0 95 233¹ NA 110 Home readiness time
et al. 2003) 600mg [35-330] from the EO. Voiding
mepivacaine was required.
SA: 6mg bupivacaine + 5 100 0 129 ¹ One patient was
15µg fentanyl [72-262] admitted to PACU:
GA: propofol +N2O, – 35 46 131 bilateral block due to
fentanyl [3-69] [48-187] protocol violation,
P<0.001 NS received GA as well
(Pollock 63 SA: lidocain 25mg+ 9 0 85±5 NA 142 ±5 40-42% had additional
et al. 2003) fentanyl 20 µg propofol infusion in both
groups. PACU time=
EPI: chloroprocaine 10 0 87±4 152 ±5 time in Phase I + Phase
15-20 ml II unit.
(Casati 40 Sciatic-femoral: 5 50 5 NA 277² ² The time in the
et al. 2002) 500 mg mepivacaine [5-20] [140-480] ambulatory surgery unit.
GA: – 5 23 170
propofol+remifentanil [10-95] [100-400]
P=0.003 P=0.001 P=0.005
(Ben-David 100 SA: 20 mg lidocaine + 0 100 0 NA 45 Ready to home from the
et al. 2001) fentanyl 20 µg [28-180] EO, neither voiding nor
IA +LA lidocaine + 6 98 0 43 [22-139] walking required.
propofol infuusion NS
(Jacobson 400 IA+LA 0.5 % 16 % NA NA NA NA 90 %, 81 % and 97 %
et al. 2000) prilocaine 40-70 ml of LA were satisfied with the
SA: lidocaine 60-90 mg not anaesthesia in IA, SA
GA: propofol + optimal and GA groups (NS)
alfentanil
(Mulroy 48 EPI: chloroprocaine 56³ 0 NA NA 92±18* ³% of the patients
et al. 2000) 15-20 ml needed propofol
SA: procaine 75mg + 253 0 146±52 infusion.
20µg fentanyl Discharge time from
GA: propofol/N2O; BIS - 0 104 ±31** arrival to PACU, voiding
40-60 required in EPI and SA
*P=0.0006 groups.
EPI vs. SA
**P=0.008
GA vs. SA
(Goranson 60 IA: 100mg lidocaine + 0 NA NA NA 117±47 Discharge from entering
et al. 1997) LA the recovery room until
FNB: 400mg 5 149±43 discharge home.
chloroprocaine Intraoperative pain VAS
FNB 400mg 0 162±98 varied from 3.3-4.9±
chloroprocaine + IA: 2.7 (NS).
100mg lidocaine
Time values (min) are either median [range] or mean ± SD.
EO = end of operation, PACU = Postanaesthesia care unit. SA = spinal anaesthesia, EPI = epidural anaesthesia, IA = intra-articular;
LA = local anaesthesia, GA = general anaesthesia, FNB = femoral nerve block
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study by Mulroy and co-workers, the discharge times after EPI (20 mg/ml chlo-
roprocaine) and GA (propofol) were comparable, whereas SA (procaine and fen-
tanyl) was associated with a longer discharge time (Mulroy et al. 2000). On the
contrary, two other studies found no difference in the time to home-readiness
after SA (lidocaine and fentanyl) and EPI (2-chloroprocaine) (Pollock et al. 2003),
or after IA lidocaine together with propofol infusion and SA (lidocaine and fen-
tanyl) (Ben-David et al. 2001). A comparison of GA and/or different regional
anaesthetic (RA) techniques used in recent studies for ambulatory knee arthros-
copy patients is given in Table 1.
General anaesthesia
The ambulatory anaesthetic agent should provide a smooth and rapid induction,
optimal surgical conditions, and fast recovery with no or minimal side effects. In a
comparison of different GA techniques for patients undergoing knee arthroscopy,
the use of inhalation anaesthetic (desflurane or sevoflurane) was associated with
faster early stage recovery (Dolk et al. 2002) and reduced drug costs (Heidvall et al.
2000; Dolk et al. 2002) compared to anaesthesia maintained with propofol.
Monitored anaesthesia care
In monitored anaesthesia care (MAC), sedative/anxiolytic drugs are used in ad-
dition to a local anaesthetic or regional anaesthesia (or for sedation when un-
pleasant diagnostic procedures are done). The anaesthetic state can vary from
conscious sedation to deep sedation without airway control (Tesniere and Servin
2003). A great variety of i.v. drugs are used to achieve MAC. An i.a. local anaes-
thetic has been used solely or in combination with MAC for knee arthroscopy
(Goranson et al. 1997; Hirshorn 2001).
Postoperative recovery and discharge
An outpatient should be a carefully selected patient who is undergoing a non-
emergency procedure and all its constituent elements (admission, surgical proce-
dure and discharge home) on the same day (Korttila 1995). An extended stay
(i.e. 23 hours or overnight) should not be considered ambulatory surgery (Mc-
Grath and Chung 2003). Recovery can be divided into three phases: early, inter-
mediate and late recovery (Korttila 1995). In the early stage of recovery, the patient
emerges from anaesthesia and is usually looked after in the abundantly equipped
and manned postanaesthesia care unit (PACU) or phase I unit. Modern short-
acting drugs in GA and techniques in RA have made the early stage recovery so fast
that some patients can be safely fast-tracked, i.e. bypass PACU (Apfelbaum et al.
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2002). The ambulatory surgery unit (ASU) or phase II unit is a less expensive unit
than the regular PACU; thus fast-tracking means savings in costs (Song et al. 1998;
Apfelbaum et al. 2002). In most studies, the modified Aldrete scoring system
(Appendix 1) has been used to determine fast-track eligibility (Aldrete and Kroulik
1970; Aldrete 1995; Song et al. 1998). For patients undergoing GA, the new fast-
tracking criteria (White and Song 1999) are more suitable, since they also take into
consideration the common side effects, nausea and pain (Appendix 2).
During the stage of intermediate recovery, the patient achieves the criteria for home
discharge (Korttila 1995; Marshall and Chung 1999). The discharge time (total
recovery time) has been used as a measure of efficacy when comparing anaesthetic
agents or techniques (Valanne 1992). However, several elements may cause confu-
sion when comparing the home-readiness. It has been demonstrated that many
non-anaesthetic related factors had an effect on discharge time, postoperative nurs-
ing care being the single most important reason (Pavlin et al. 1998). A validated
postanaesthesia discharge scoring system has been created by Chung and co-workers
(1995) basing on stable vital signs, ability to walk, no or minimal pain, no or
minimal postoperative nausea and vomiting, absence of severe bleeding, and ability
to tolerate fluids, and void (Appendix 3). Various criteria are nevertheless used.
During the past few years, the home discharge criteria have been changed.
Mandatory drinking has been eliminated from the Practice Guidelines for Pos-
tanaesthetic Care (The American Society of Anesthesiologists 2002) and, accord-
ing to these guidelines, the routine requirement of voiding before discharge has
also been recommended to be necessary only for selected patients (i.e. high-risk
patients). After GA, local or peripheral nerve block, urinary retention affected
0.5% of the patients who were categorized as low-risk patients (non-pelvic
surgery or outpatient gynaecological surgery), whereas in high-risk patients
(hernia or anal surgery or a history of retention) the incidence was 5%. The rate of
re-retention after anal surgery was as high as 50% (Pavlin et al. 1999). The
patients should be informed to seek immediate medical help if they are unable to
void 6-8 hours after discharge (McGrath and Chung 2003).
In most studies, ambulating without help has been mandatory before being
judged home-ready, whereas in other studies, only the ability to stand or walk
with crutches was required (Ben-David et al. 2001; Borghi et al. 2003). In GA
studies, the time to reach home-readiness is usually measured from the end of
surgery, whereas in RA studies it is measured from the beginning of the injection
of the local anaesthetic. The lack of identical fast-tracking and home-readiness
criteria between studies makes the evaluation of the efficacy of different anaes-
thetic agents and techniques difficult.
In late recovery, the patient returns to the preoperative physiological state
(Marshall and Chung 1999). Despite its subjective nature, patient satisfaction
has been included in outcome studies. Overall satisfaction with low-dose spinal
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anaesthesia ranges from 92-99% of the patients (Chung and Mezei 1999; Kuus-
niemi et al. 2000a; Kaya et al. 2004).
Spinal anaesthesia in ambulatory surgery
Unilateral spinal anaesthesia
As long as 40 years ago, Tanasichuk and co-workers (1961) used a “spinal hemi-
analgesia” technique, by which they tried to limit the spread of spinal block to
one side of the body by using a hyperbaric solution, a pencil-point needle and a
lateral decubitus position. Several words such as restricted, asymmetric or unilat-
eral spinal anaesthesia are used to describe the spinal anaesthesia developing mainly
on one side of the body. Most often the criteria for unilateral spinal block have
been described as absence of sensory and motor block on the nondependent side,
but some investigators have determined also the degree of sympathetic block i.e.,
strictly unilateral spinal anaesthesia (Tanasichuk et al. 1961; Meyer et al. 1996;
Enk et al. 2001).
According to Enk (Enk 1998; Enk et al. 2001), it is possible to inject a local
anaesthetic solution i.t. in such a way that the hyperbaric anaesthetic forms a layer
below the cerebrospinal fluid (CSF) enabling thus, a strictly unilateral spinal an-
aesthesia. Injection of an anaesthetic with high outflow velocity through a small-
bore spinal needle causes turbulence and further mixing up with the CSF, com-
pared with a slow injection flow (Enk et al. 2001). Today, smaller needles are
used to avoid the risk of postdural puncture headache (PDPH). Halving of the
diameter of the needle results in a fourfold flow velocity within the spinal needle.
Thus, the smaller the needle, the slower the injection should be to avoid turbu-
lence (Enk 1998). With an indermediate amount of 5 mg/ml hyperbaric bupi-
vacaine (1.4 to 1.7 ml) Enk and co-workers (2001) were able to produce a unilat-
eral sensory spinal block to 48% versus 10.5% of the patients (P<0.05), when they
compared a low-flow (0.5 ml/min) injection (27-G Whitacre) with conventional
flow (7.5 ml/min), respectively. On the other hand, Casati and co-workers (1998c)
found the incidence of unilateral sensory block to be equal, when they injected 8
mg of hyperbaric bupivacaine (1.6 ml) either at a low flow of 0.02 ml/s (1.2 ml/
min) or a high flow of 0.25 ml/s (15 ml/min) (25-G Whitacre), 56% vs. 43%,
respectively. However, the low-flow was over twofold faster (1.2 ml/min vs. 0.5
ml/min) and the maintenance of the lateral decubitus was shorter (15 vs. 30
min) in the latter study.
Selective spinal anaesthesia
In selective spinal anaesthesia (SSA), minimal doses of intrathecal agents are used,
so that only the nerve roots supplying a specific area, and only the modalities that
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need to be anaesthetized, are affected (Vaghadia 1998). Most often the term SSA
has been used of spinal anaesthesia produced for gynaecological laparoscopies
(bilateral block), whereas the name unilateral spinal anaesthesia is used more of-
ten of the block developing mainly to one side of the body. In both techniques,
however, low doses of local anaesthetics are administered.
Compared with a conventional dose of lidocaine 75 mg, SSA with 25 mg of
lidocaine together with 25 µg of fentanyl enabled faster recovery from motor and
sensory blocks, as well as a 40 min shorter time to meet home discharge criteria
after laparoscopy (Vaghadia et al. 1997). The comparison of SSA with three low-
dose solutions showed that either 20 mg of hypobaric lidocaine combined with 25
µg fentanyl, or 10-20 mg lidocaine combined with 10 µg sufentanil can be used
for ambulatory laparoscopy, but the combination of 10 mg of lidocaine and 10 µg
of sufentanil was associated with the fastest recovery from sensory block. The recov-
ery times from motor block were equal after all three solutions (Vaghadia et al.
2001). The laparoscopy patients had significantly faster early stage recovery and
ability to ambulate after SSA with 10 mg of lidocaine together with 10 µg sufen-
tanil, compared with GA with either propofol (Stewart et al. 2001) or desflurane
(Lennox et al. 2002b). For anorectal surgery, the SSA was produced by using 5 mg
of hypobaric bupivacaine for the patients in a prone, jack-knife position. The medi-
an level of upper sensory level was L1 and no patient developed motor block. The
postoperative analgesia lasted up to 340 min (Maroof et al. 1995).
The advantages of unilateral or selective versus conventional SA are: better
haemodynamic stability (Tanasichuk et al. 1961; Pittoni et al. 1995; Vaghadia et
al. 1997; Fanelli et al. 2000), faster motor and sensory recovery (Vaghadia et al.
1997; Vaghadia 1998; Fanelli et al. 2000) and decreased risk of urinary retention
(Ben-David et al. 1996; Ben-David et al. 1997; Ben-David et al. 2000; Kuusnie-
mi et al. 2000a; Mulroy et al. 2002). The patients’ satisfaction with the unilateral
techniques has been high, too (Pittoni et al. 1995; Kuusniemi et al. 1997; Kuus-
niemi et al. 2000a).
The quality of spinal anaesthesia
The spread of spinal anaesthesia
Greene reported 25 factors that could affect the distribution of the local anaes-
thetic in the cerebrospinal fluid (Greene 1985), but not all of them have clinical
relevance. These factors can be classified into 4 subgroups: characteristics of the
patient and of the CSF, characteristics of the local anaesthetic agent, and the
injection technique used (Table 2). Besides the drug dosage, the position of the
patient at the time of injection and thereafter, together with the baricity of the
anaesthetic, are the most important factors affecting the level of spinal anaesthe-
sia (Stienstra and Greene 1991; Connolly and Wildsmith 1998; Enk 1998).
16 REVIEW OF THE LITERATURE
Anatomy
The spinal cord, covered by a bony vertebral column, extends from the level of
the atlas vertebra downward, ending as the conus medullaris, which is usually
situated between the 1st and 2nd lumbar vertebrae. The spinal cord is situated in
the middle of the spinal canal, where it is surrounded by 3 connective tissue
membranes: the pia mater, the arachnoid mater and the dura mater. Between the
pia and arachnoid mater is the subarachnoid, i.e. the intrathecal space, filled with
cerebrospinal fluid (CSF). The 31 pairs of spinal nerves exit the spinal canal through
each intervertebral foramen. Each spinal nerve supplies a specific area of the skin
(i.e. dermatomes) and a specific number of muscles (i.e. myotomes), although
there is overlapping between the segmental distribution. The nerves below the
conus form the cauda equina, and they are situated inside the dural sac surround-
ed by CSF. Intrathecally administrated local anaesthetic agents are injected into
the CSF below the level of the conus, where the nerves are devoid of perineural
tissue. Thus, there is only little resistance to the action of local anaesthetic, which
explains the rapid onset of spinal anaesthesia (Kahle et al. 1986; Mulroy 2002b).
Injection technique of unilateral or selective spinal anaesthesia
In creating a unilateral or selective spinal anaesthesia with low doses of intrathe-
cal agents, the injection technique becomes especially important. Enk (1998)
concluded the importance of “low-dose, low-volume and low-flow” for produc-
Table 2. Elements influencing the spread of spinal anaesthesia in addition to the injection technique.
Element Influence Reference
Patient characteristics
patient position major importance (Greene 1985; Enk 1998)
increasing age no clear correlation (Pitkänen et al. 1984; Pitkänen 1987)
height not within normal variation (Pitkänen 1987)
BMI higher spread with increased BMI (Pitkänen 1987; Taivainen et al. 1990)
pregnancy higher spread (Hirabayashi et al. 1995b)
gender no (Greene 1985)
Cerebrospinal fluid (CSF)
volume decreasing volume increases the sensory (Hogan et al. 1996; Carpenter et al. 1998;
spread; 2-3 -fold variety in the volume of Higuchi et al. 2004)
CSF between individuals
density a higher sensory spread after plain solution (Schiffer et al. 2002; Higuchi et al. 2004)
when the density of CSF increases
Anaesthetic agent
dose major importance (Greene 1985; Enk 1998)
baricity major importance (Greene 1985; Enk 1998)
concentration only minor effects (Casati et al. 1998b)
Injection technique major importance See text.
BMI = body mass index
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ing unilateral spinal anaesthesia. The extent of hyperbaric spinal anaesthesia in-
fluences the duration of the block. When a significantly higher sensory spread
followed after the injection of the same dose of lidocaine, a faster recovery of
sensory and motor block, and earlier fulfilment of home-readiness were seen com-
pared to a lower sensory block (Urmey et al. 1997). It was also demonstrated
that with the same dose of hyperbaric bupivacaine, the duration of both sensory
and motor block is longer in patients with restricted block (Kooger Infante et al.
2000). This might explain the high failure rate with low-dose i.t. anaesthetic in
some studies (Ben-David et al. 1997): if the spread is not restricted, the risk of
inadequate spinal block may increase.
As mentioned earlier, the position of the patient (sitting, lateral decubitus
position, prone) is essential with respect to the baricity of the local anaesthetic.
The maintenance of the selected position affects the spread of anaesthesia. After
7.5 or 10 mg of i.t. hyperbaric bupivacaine the sensory and motor blocks were
more unilateral, when the patients were kept 10 or 15 min in the lateral decubi-
tus position compared with 5 min time. With a higher dose of hyberbaric bupi-
vacaine, i.e. 12.5 mg, 90-100% of the patients developed a bilateral block when
the lateral decubitus position was maintained for 5 to 10 min, and even with 15
minutes spent in the lateral decubitus position, 50% of the patients had bilateral
block (Esmaoglu et al. 1998). When the influence of 20 versus 30 min time spent
in the lateral decubitus position on the possibility to develop unilateral block was
evaluated, both the level of sensory block and the incidence of unilateral sensory
block were similar with 6.12 mg of hypobaric bupivacaine. Although the unilat-
eral motor block was achieved more often after 30 min in the lateral decubitus
position, the longer time spent in this position did not have an effect on motor
recovery (Kuusniemi et al. 1997).
The earlier finding that hyperbaric rather than hypobaric bupivacaine can
facilitate the development of unilateral block (Kuusniemi et al. 2000a), was con-
firmed in a recent study comparing hyperbaric and hypobaric i.t. bupivacaine
(Kaya et al. 2004). All the patients were kept in a lateral decubitus position for 15
min before turning them supine. At 15 min, the incidence of unilateral block was
equal, 80% versus 76% of the patients, respectively. But 15 min after the patients
had been turned supine, 68% of the patients in the hyperbaric group compared
with 24% in the hypobaric group, had unilateral block. The maximum level of
the sensory block on the operative side did not spread higher after the patient
had been turned supine. With conventional doses of bupivacaine (i.e. 15 mg
plain/hyperbaric), the change in position as late as 80-115 min after spinal injec-
tion increased the level of sensory block by 1 to 4 segments (Povey et al. 1989;
Niemi et al. 1993).
The injection site is one factor influencing the intrathecal spread. Unfortu-
nately, the ability of an anaesthetist to predict a certain lumbar interspace has
been shown to be poor: 59-85% of anaesthetists failed to identify lumbar inter-
spaces correctly (Van Gessel et al. 1993; Broadbent et al. 2000). A higher level of
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sensory block was noted when 3 ml of plain bupivacaine was injected at the L2/
3 interspace compared to the L4/5 interspace (Tuominen et al. 1989). On the
other hand, when a higher dose (4 ml) of plain bupivacaine, was injected either at
L2/3 or L3/4 interspace, no effect was found on sensory block level (Olsen et al.
1990). The use of a large dose and the 2-min time in the sitting position might
have had an influence on the overall spread.
Finally, the needle type affects the spread of spinal anaesthesia as well as the
direction of the spinal injection. As early as in 1961, Tanasichuk found a higher
incidence of spinal hemianalgesia with the use of a pencil-point needle (Whita-
cre) compared to a non-directional (Pitkin) needle: 67% versus 30% of the pa-
tients, respectively (Tanasichuk et al. 1961). In a more recent study, 66% of the
patients had a unilateral sensory block with a Whitacre needle compared to 16%
of the patients with a Quincke needle (Casati et al. 1998a). When 60 mg of plain
lidocaine was injected through a Whitacre needle, either with the aperture of the
needle cephalad or caudally oriented, a higher sensory spread was found with the
cephalad-oriented injection than with the caudally directed injection: Th3.4 ±
1.3 versus Th6.6 ±2.8 (P<0.001), respectively (Urmey et al. 1997).
Spinal anaesthetic agents
Local anaesthetics
A local anaesthetic agent inhibits neural transmission by blocking the conduct-
ance of sodium into the cell and thus making depolarization impossible. In Fin-
land, all intrathecally administered local anaesthetics, including lidocaine, mepi-
vacaine, bupivacaine, ropivacaine and levobupivacaine, are amino-amides. Ami-
no-esters such as short-acting procaine and long-acting tetracaine are used for
spinal anaesthesia elsewhere.
Since 1948, hyperbaric lidocaine has been widely used as a spinal agent for
procedures of short duration. Both serious neurological injury (cauda equina
syndrome) (Rigler et al. 1991; Schell et al. 1991) and transient neurological
symptoms (TNS) (Schneider et al. 1993) were reported after the use of lidocaine
in the beginning of 1990. Later, the incidence of TNS after short-acting lido-
caine and mepivacaine has been 16-37% (Hampl et al. 1996; Hiller and Rosen-
berg 1997; Salmela and Aromaa 1998; Hiller et al. 1999; Pollock et al. 1999;
Pollock 2003). These observations guided the researcher to look for other suita-
ble spinal agents for outpatients.
The incidence of TNS after long-acting bupivacaine has been shown to be
considerably lower, 0-3% (Hiller and Rosenberg 1997; Kuusniemi et al. 1997;
Keld et al. 2000; Kuusniemi et al. 2000a), making the use of bupivacaine an
attractive option for SA. In a dose-response study of hyperbaric bupivacaine (3.75
– 11.25 mg) in volunteers, each additional mg of bupivacaine increased the time
to home readiness by 21 min (Liu et al. 1996). In clinical studies, bupivacaine
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(after a dose reduction from a conventional dose) has been shown to be suitable
for outpatients. For ambulatory patients undergoing knee arthroscopy, both low
doses of bupivacaine (4-6 mg) (Kuusniemi et al. 1997; Kuusniemi et al. 2000a;
Borghi et al. 2003) and medium-low doses (6-8 mg) (Casati et al. 1998b; Fanelli
et al. 2000; Enk et al. 2001; Borghi et al. 2003; Kaya et al. 2004) have been used
successfully.
Ropivacaine, the S-isomer of the propyl homologue of bupivacaine (White-
side et al. 2001) has approximately 50% of the potency of bupivacaine at equal
doses, when administered i.t. (Gautier et al. 1999; McDonald et al. 1999). The
incidence of TNS has been 0-6% after spinal ropivacaine (Gautier et al. 1999;
McDonald et al. 1999; Buckenmaier et al. 2002). For ambulatory knee arthros-
copy, the use of ropivacaine has not offered benefits over bupivacaine. The senso-
ry and motor blocks recovered faster after a 10 mg dose of i.t. ropivacaine than
after 8 mg of bupivacaine, but the quality of intraoperative analgesia was also
significantly lower with ropivacaine (Gautier et al. 1999). Increasing the dose of
ropivacaine to 12 mg, the recovery from SA was similar to that after 8 mg of
bupivacaine (Gautier et al. 1999). The combination of 8 mg of ropivacaine and
15 µg of clonidine provided better analgesia for knee arthroscopy than 8 mg of
ropivacaine alone and a recovery times suitable for outpatients (De Kock et al.
2001). Surprisingly few studies have been done with low-dose i.t. ropivacaine
and opiods.
Levobupivacaine is the S-enantiomer of bupivacaine with a lower degree of
cardiotoxicity compared to racemic bupivacaine (Whiteside and Wildsmith 2001).
Cardiotoxicity is not relevant with the bupivacaine doses (up to 20 mg) used in
spinal anaesthesia. No difference was found between the spinal block after i.t.
bupivacaine or levobupivacaine (Alley et al. 2002).
Adjuncts
Vasoconstrictors (adrenaline, phenylephrine), alpha-2-agonists (clonidine), ace-
tylcholine esterase inhibitors (neostigmine) and opioids (morphine, fentanyl and
sufentanil) have been used as additives, with local anaesthetics for SA (Table 3).
Because the use of i.t. adjuncts mainly aims to prolong the anaesthetic action,
only a few of them are suitable for outpatients.
Low doses of i.t. opioids improve intraoperative analgesia (Abouleish et al.
1988; Liu and McDonald 2001) and the quality of anaesthesia (Ben-David et al.
1997; Goel et al. 2003). The effects on motor recovery and discharge are contro-
versial, however. Most of the studies with a combination of low-dose local anaes-
thetic and fentanyl have found no delays on discharge (Vaghadia et al. 1997; Ben-
David et al. 2000; Ben-David et al. 2001; Vaghadia et al. 2001; Lennox et al.
2002b; Jankowski et al. 2003), whereas Goel and co-workers showed a signifi-
cant prolonging of motor block when 5 mg of bupivacaine was administered
together with 10–12.5 µg of fentanyl compared to a 7.5 µg dose (Goel et al.
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2003). This study was conducted in a single-blinded fashion. However, with
higher doses (bupivacaine 10 mg and fentanyl 25 µg compared to bupivacaine
10 mg alone), a similar effect was found (Kuusniemi et al. 2000b). Hydrophilic
morphine as an i.t. adjunct has been shown to produce long-lasting (24 h) post-
operative analgesia (Abboud et al. 1988). The slow onset time, long duration of
action, and a rare, but dangerous complication of late respiratory depression (Liu
and McDonald 2001) limits the use of spinal morphine to inpatients. Even a
mini-dose of i.t. morphine (50 µg) together with bupivacaine caused a 3-4 h
delay in the ability to void, when compared with bupivacaine-fentanyl or bupi-
vacaine alone, respectively (Gürkan et al. 2004).
Lipophilic opioids have a shorter duration of action than morphine, and the
risk of respiratory depression is small with low-dose fentanyl (10-25 µg) (Liu and
McDonald 2001). The use of i.t. fentanyl 10-25 µg together with a low dose of
lidocaine or bupivacaine, is common in day surgery. The minimum effective dose
of fentanyl is 10 µg (Liu and McDonald 2001). Sufentanil 10µg has been used
successfully together with low-dose lidocaine 10-20 mg in producing SSA for
gynaecological laparoscopy (Vaghadia et al. 2001), whereas i.t. 20 µg of sufen-
tanil alone was unsuitable for the procedure (Henderson et al. 2001).
Table 3. Effects of certain adjuncts on the spinal anaesthesia with ambulatory patients.
Adjunct Time of recovery Quality Side effects Reference
Adrenaline
0.2 mg and 7.5 mg delayed prolonged toleration NA (Moore et al. 1998)
bupivacaine versus of TES
bupivacaine alone
Clonidine
15 µg and ropivacaine delayed, improved – (De Kock et al.
8 mg but suitable 2001)
for outpatients
45-75 µg and delayed hypotension, (De Kock et al.
ropivacaine 8mg versus sedation 2001)
ropivacine alone
Neostigmine
6.25 µg – 50 µg + delayed no effect/ nausea, vomiting, (Liu et al. 1999)
bupivacine 7.5mg versus prolonged toleration sedation
bupivacaine alone of TES
Low-dose Opioid
morphine delayed improved PONV, respiratory
depression, dysuria, See text.
pruritus
fentanyl, sufentanil controversial improved PONV, pruritus See text.
TES = transcutaneous electrical stimulation, PONV = postoperative nausea and vomiting
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Failure of spinal anaesthesia
In a study of 1891 patients, the overall failure rate of conventional SA was found
to be 3.1% after i.t. lidocaine or bupivacaine (Tarkkila 1991). In a recent study of
2603 orthopedic patients undergoing spinal anaesthesia, only 1% of the blocks
failed after conventional SA with bupivacaine (Puolakka et al. 2000). When dif-
ferent needles were compared, the incidence of failure varied from 5.5 to 8.5% in
orthopaedic inpatients with a 27-gauge pencil-point (Whitacre) or cutting nee-
dle (Quincke), respectively (Lynch et al. 1994) and from 7 to 7.7% in gynaeco-
logical inpatients when using either an Atraucan (26-gauge) or Whitacre (25-
gauge) needle (Pan et al. 2002).
With low-dose (not unilateral) spinal bupivacaine 5 mg, a failure rate as high
as 24% was reported, but when 5 mg of bupivacaine was combined with 10 µg of
fentanyl, the failure rate fell to 0% (Ben-David et al. 1997). After bupivacaine 5
mg combined with either 10 or 7.5 µg of fentanyl in ambulatory urological
patients, 13-27% of the blocks failed, whereas with a fentanyl dose of 12.5 µg, no
failures occurred (Goel et al. 2003). Other investigators have reported a lower
incidence of failure with (unilateral) low-dose spinal bupivacaine for patients
undergoing knee arthroscopy. Plain or hyperbaric bupivacaine 4–8 mg resulted
in a 0% incidence of failure (Kuusniemi et al. 2000a; Kuusniemi et al. 2001;
Borghi et al. 2003; Kaya et al. 2004), after 5-12 mg of hyperbaric bupivacaine
(dose adjusted to the height of the patient) 2.5% failed (Pittoni et al. 1995) and
finally, a failure rate of 6% after 8 mg of hyperbaric bupivacaine either with unilat-
eral or bilateral SA technique was noted (Fanelli et al. 2000). After a low dose of
lidocaine (20 mg) together with fentanyl (20–25 µg) for knee arthroscopy, no
failures were reported (Ben-David et al. 2000; Ben-David et al. 2001). When SSA
was produced for gynaecological procedures with lidocaine and fentanyl or suf-
entanil, 20-50% of the patients needed intravenous opioids because of shoulder
pain, but the need to convert to general anaesthesia was low or nonexistent (Va-
ghadia et al. 1997; Vaghadia et al. 2001; Lennox et al. 2002b).
Side effects of spinal anaesthesia
Hypotension
Hypotension occurs in 8.2 - 33% of the patients receiving SA, but as many as 81%
of the patients develop episodes of hypotension when the peak sensory block
exceeds Th5 (Tarkkila and Kaukinen 1991; Carpenter et al. 1992; Tarkkila and
Isola 1992). SA causes sympathetic block, which results in arteriolar dilatation
and venous pooling (decreasing systemic vascular resistance) and further hypo-
tension. The venous pooling reduces venous blood return to the heart and can
decrease cardiac output and cause hypotension (Carpenter et al. 1992). The level
of the sympathetic block (Tarkkila and Isola 1992), the intravascular volume
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status, as well as age, affect the extent of decrease in blood pressure (Pitkänen et
al. 1984; Tarkkila and Isola 1992).
Bradycardia
The overall incidence of bradycardia after SA is 8.9-13% (Tarkkila and Kaukinen
1991; Carpenter et al. 1992; Tarkkila and Isola 1992), but may be as high as 75%
when peak sensory block extends > Th5. If the sympathetic cardio-accelerator
fibres from Th1 to Th5 are blocked, the vagal parasympathetic tone predomi-
nates, resulting in mild to moderate bradycardia (Salinas et al. 2003). Bradycar-
dia may occur after decreased venous return or stimulus such as traction on the
peritoneum, but it can remain unexplained, too (Mulroy 2002b). Risk factors for
bradycardia (heart rate < 50 bpm.) are baseline heart rate < 60 bpm, the use of
β-blockers, ASA physiological status I (Liu and McDonald 2001).
Cardiac arrest resulting from severe hypotension and bradycardia is an infrequent
side effect of SA. In a prospective survey in France, 41000 spinal blocks were
performed during a 10-month follow-up: 10 cardiac arrests occurred (2.7/10000)
after SA (Auroy et al. 2002), whereas in a Finnish study, 2 out of 550000 SA
patients developed cardiac arrest (Aromaa et al. 1997).
Since the SA-induced hypotension is related to the level of sensory block, it is
reasonable to try to restrict the spread of SA. Decreased haemodynamic changes
after unilateral and selective spinal anaesthesia techniques have been demonstrated
in several studies (Tanasichuk et al. 1961; Kuusniemi et al. 1997; Vaghadia et al.
1997; Kuusniemi et al. 1999; Fanelli et al. 2000; Kuusniemi et al. 2000a).
Neurological sequelae
Serious permanent neurological injury after SA is rare, but when it occurs, it is
a catastrophic complication (Dripps and Vandam 1954; Vandam 2004). In an
important study by Dripps and Vandam (Dripps and Vandam 1954), early and
late effects of SA were studied after 10098 spinal blocks: after a 6-month fol-
low-up only one case of serious neurological injury was found, affecting a pa-
tient with an asymptomatic meningioma. Case-reports of cauda equina syn-
drome after continuous SA with lidocaine in 1991 (Rigler et al. 1991; Schell et
al. 1991) aroused concern against both the continuous i.t. technique and the
neurotoxicity of i.t. lidocaine. More recently, seven cases, in which the conus
medullaris was damaged following spinal anaesthesia, were described: Bupi-
vacaine was used through an atraumatic needle, injected at L2/3 interspace,
and all patients reported pain on insertion of the needle. Six of the patients
were obstetric, and one was obese (Reynolds 2001). Aromaa and co-workers
(1997), however, found the incidence of serious neurological complications to
be low: 0.003% following SA and 0.002% following EPI, based on patients
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claims in Finland during the years 1987–1993. Auroy and co-workers (2002)
reported the incidence of serious neurological injury to be 0.01% after spinal,
and 0.003% after epidural anaesthesia.
The term transient neurological symptoms (TNS) is described today as uni-
lateral or bilateral pain in the anterior or posterior thighs with or without exten-
sion into the legs and back after recovery from SA (Pollock 2003). The first
studies used the name transient radicular irritation (TRI), but it was replaced by
TNS, because a definitive aetiology was lacking and, it described these symptoms
better, as they had a possible neurological origin, but were more musculoskeletal
in nature (Rowlingson 2000; Faccenda and Finucane 2001; Pollock 2003). TNS
were first described as late as 1993, by Schneider and co-workers after a single-
shot spinal anaesthesia with 5% lidocaine (Schneider et al. 1993). Since then, a
number of randomized, controlled studies have been conducted to determine
the incidence and aetiology of TNS after spinal anaesthesia. Although the exact
mechanism remains unclear, it is now known that the highest incidence of TNS
occurs after lidocaine SA (10-37%) compared to other local anaesthetics, and in
patients undergoing knee arthroscopy (18–22%) or surgery in the lithotomy
position (30–36%) (Pollock 2003). Neither the dilution of lidocaine (Pollock et
al. 1999) nor the use of isobaric rather than hyperbaric solution have decreased
the occurrence of TNS significantly (Eberhart et al. 2002). After a reduced dose
of lidocaine (1% hypobaric) 50 mg, TNS occurred in 33% of the patients, but
with a mini dose of lidocaine 20 mg together with fentanyl 25 µg, only 4% of the
patients developed TNS (Ben-David et al. 2000).
Although the aetiology of TNS remains unclear, some authors have recom-
mended to avoid the use of i.t. lidocaine in unilateral spinal anaesthesia (Enk
1998) and in certain patient groups (ambulatory knee arthroscopy and proce-
dures where nerve stretching is possible, like lithotomy position), because of the
high risk of TNS in these patients (de Jong 1994; Pollock 2003).
Postdural puncture headache
Intense headache after SA was reported after the first spinal anaesthesias given,
and Bier himself was affected by this headache when the spinal block was admin-
istered to him in 1898 (Spencer 1998). By that time, up to 66 % of the patients
developed postdural puncture headache (PDPH), due to the use of large gauge,
cutting spinal needles (Turnbull and Shepherd 2003). Today, the incidence of
PDPH is less than 3% (Mulroy and McDonald 2003), when smaller-gauge and
pencil-point needles are used. Although it is known that the dural puncture leads
to CSF leakage through a needle-induced dural hole, and further to lower CSF
pressure, the actual mechanism behind the PDPH remains unclear (Turnbull and
Shepherd 2003).
PDPH can be described as a headache appearing within the first three days or
even a week after a certain or possible dural puncture, worsened by an upright
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position and relieved when lying down. It lasts over 24 hours, being usually a
frontal or occipital headache, but it can be associated with photophobia, neck
stiffness, tinnitus and/or nausea. The majority of the patients with PDPH recov-
er spontaneously in 5 to 10 days (Horlocker 2000). Mild to moderate symptoms
can be treated conservatively with bed rest, hydration, analgesics and caffeine.
However, in the case of severe symptoms, an epidural blood patch is the treat-
ment of choice with a success rate of over 90% (Horlocker 2000).
Several risk factors for PDPH have been identified. The incidence of PDPH
decreases in patients older than 40-50 years of age (Mulroy and Wills 1995; Eriks-
son et al. 1998). Women have been considered to have an increased risk for PDPH
(Dripps and Vandam 1954; Despond et al. 1998; Eriksson et al. 1998), although
an opposite result has been found, too (Seeberger et al. 1996). The most impor-
tant factor is the type and the size of the needle. A recent study with 529 outpa-
tients showed the incidence of PDPH to be higher when using a 27-G Quincke
vs. a 27-G Whitacre needle: 2.7% versus 0.37% (P<0.05), respectively (Santanen
et al. 2004). In a meta-analysis, a reduction in the incidence of PDPH was seen
when a small-gauge spinal needle vs. a large needle of the same type, and when a
non-cutting rather than a cutting spinal needle was used (Halpern and Preston
1994). The risk of PDPH increases also if repeated dural punctures are required.
After a single puncture vs. multiple punctures, the incidence of PDPH was found
to be 1.6% compared to 4.2% (P < 0.02), respectively (Seeberger et al. 1996).
Difficulties in voiding
The incidence of postoperative urinary retention is controversial. After a conven-
tional dose of i.t. bupivacaine, the incidence of urinary retention was as high as
30% (Mulroy et al. 2002). On the other hand, a certain type of surgery (hernia or
anal surgery), or a history of retention increased significantly the risk of urinary
retention in patients receiving GA, local or peripheral nerve block compared to
patients undergoing non-pelvic procedures (Pavlin et al. 1999). When long-last-
ing local anaesthetics, even at reduced doses, are used i.t., their effects on voiding
should be taken into consideration. The detrusor block after SA with long-act-
ing bupivacaine (10 mg hyperbaric) lasted much longer than after short-acting
lidocaine (100 mg hyperbaric), 462 min versus 233 min (P=0.0002), whereas
the motor block lasted only 148 versus 144 min, respectively (Kamphuis et al.
1998). The abilty to void was 40 min shorter after lidocaine 60 mg, than after
levobupivacaine 10 mg or ropivacaine 15 mg: 245 min versus 284 and 285 min,
respectively (P < 0.05) (Breebaart et al. 2003). Because the delayed return of
bladder function may lead to overdistension and further to urinary retention
(Mulroy et al. 2002), ambulatory patients have been required to void before
discharge.
On the other hand, several researchers have reported a very low frequency of
urinary problems associated with low-dose SA or EPI either after a local anaes-
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thetic solution alone or in combination with a low dose of lipophilic opioid
(Ben-David et al. 1996; Ben-David et al. 1997; Ben-David et al. 2000; Kuusnie-
mi et al. 2000a; Mulroy et al. 2000; Mulroy et al. 2002). Since discharge is often
delayed because of the requirement of voiding (Mulroy et al. 2002), it has been
suggested that the requirement of urination before discharge should be manda-
tory only in selective patients (Ben-David et al. 2000; 2002; Mulroy et al. 2002).
Finally, in a study of Mulroy and co-workers this practice was evaluated by per-
forming a bladder ultrasound to those patients who did not void spontaneously.
The authors concluded that voiding could be omitted before discharge home in
outpatients after spinal anaesthesia when using a short-acting spinal anaesthetic
or hyperbaric bupivacaine < 7mg in patients with low risk of urinary retention
(Mulroy et al. 2002).
Backache
Non-radiating backache has been reported in 33% of the patients undergoing SA
(lidocaine) and in 20% of the patients receiving GA (Hiller et al. 1999). One
important factor affecting postoperative back pain is the duration of surgery, and
it is not related to the anaesthesia method (i.e. GA, SA, EPI) used (Faccenda and
Finucane 2001). The incidence of backache rises from 18%, with surgery lasting
less than 1 h, up to 50% when the operation time exceeds 4 h (Faccenda and
Finucane 2001). Schwabe and Hopf investigated persistent back pain after SA
and found that after 5 days 11% and after 3 months 12% of the patients had back
pain, but 99.2% of these patients had suffered from back pain already before
spinal anaesthesia. They concluded that the incidence of a new backache after SA
was 0.8% (Schwabe and Hopf 2001). The type of needle affected the incidence of
backache, being 21% after Quincke (G25 -27) and 17% after Whitacre (G22 – 27)
needles (P<0.05). Also the number of skin punctures influenced the incidence of
back pain: after one puncture it was 17% and after multiple punctures 27% (P<0.01)
(Eriksson et al. 1998).
Pruritus
The incidence of pruritus induced by i.t. opioids is high even after low doses: 60-
85% with i.t. or epidural morphine (Yeh et al. 2000; Kjellberg and Tramèr 2001),
50-68% with i.t. fentanyl (Vaghadia et al. 1997; Ben-David et al. 2001; Vaghadia
et al. 2001) and 40-80% with i.t. sufentanil (Vaghadia et al. 2001; Lennox et al.
2002b; Waxler et al. 2004). Although annoying, the pruritus induced by i.t.
fentanyl or sufentanil is seldom severe (Ben-David et al. 1997; Kuusniemi et al.
2000b; Buckenmaier et al. 2002). After i.t. morphine, the pruritus may last up to
13 h (Yeh et al. 2000), but after i.t. lipophilic opioids the duration of pruritus
has not been reported. Several drugs, like propofol (Warwick et al. 1997; Beilin
et al. 1998; Yeh et al. 2000), 5-hydroxytryptamine3 (5-HT3) receptor antagonists
26 REVIEW OF THE LITERATURE
(Borgeat and Stirnemann 1999; Yeh et al. 2000; Gürkan and Toker 2002) and
droperidol (Kjellberg and Tramèr 2001) have been studied in treating or pre-
venting pruritus, but with contradictory results. The µ-receptor antagonists,
naloxone, naltrexone and nalbuphine, have been shown to be effective, suggest-
ing therefore the involvement of the µ-receptors in the mechanism of intrathecal
opioid induced pruritus. Naloxone is widely used for the treatment of opioid-
induced pruritus, but the possibility of reversing the analgesic effect of the i.t.
opioids limits the use of naloxone during surgery (Kjellberg and Tramèr 2001).
Postoperative nausea and vomiting (PONV)
PONV is traditionally considered to be one of the most frequent side effects after
general anaesthesia, and the literature concerning PONV has focused on patients
undergoing GA (Borgeat et al. 2003). Nausea is, however, a common side effect
associated with SA, too (Tarkkila and Kaukinen 1991; Carpenter et al. 1992;
Tarkkila and Isola 1992). Female sex increased the risk of nausea, as did a higher
sensory level of the block, and opioid premedication (Tarkkila and Kaukinen
1991; Tarkkila and Isola 1992). In a recent review (not systematic) by Borgeat
and co-workers (2003), the authors concentrated on PONV after RA and con-
cluded that female gender might be a risk factor for PONV also after RA, but
other patient-related risk factors should be further investigated. Crocker and Van-
dam (1959) found that hypotension increased the risk of nausea or vomiting in
patients undergoing SA. The incidence of hypotension after unilateral spinal an-
aesthesia (5-7%) (Kuusniemi et al. 1999; Kuusniemi et al. 2000a) and SSA (0%)
(Chilvers et al. 1997; Vaghadia et al. 1997) has been low when compared with
conventional SA (15-33%) (Carpenter et al. 1992; Tarkkila and Isola 1992), but
findings on the frequency of nausea and vomiting have been controversial.
Borgeat and co-workers (2003) reported that spinal morphine induced PONV
dose-dependently, whereas lipophilic opioids, fentanyl and sufentanil, had no or
only little effect on PONV. This is in contrast with recent studies in outpatients
undergoing SA with low-dose local anaesthetics together with i.t. opioids. Al-
ready a dose of 50 µg of i.t. morphine together with 6 mg of bupivacaine in-
duced nausea to 35% of the patients compared to 0% with i.t. bupivacaine alone
(Gürkan et al. 2004) and furthermore, the incidence of nausea was 20-27% after
i.t. fentanyl 20-25 µg (Ben-David et al. 2001; Pollock et al. 2003) and up to 30%
after i.t. sufentanil 10 µg (Vaghadia et al. 2001; Lennox et al. 2002b). On the
other hand, in the studies with low-dose i.t. fentanyl, the risk of PONV de-
creased: 5-7% of the patients suffered from PONV after low-dose bupivacaine
combined with 7.5–15 µg of fentanyl (Goel et al. 2003; Jankowski et al. 2003).
Other adjuncts, such as neostigmine, have been shown to cause PONV, too.
Even a low dose of i.t. neostigmine (6.25 mg) together with bupivacaine 7.5 mg
induced PONV to 33% of the volunteers compared to 0% of the volunteers with
the same dose of bupivacaine alone (Liu et al. 1999).
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Management of general anaesthesia in
ambulatory surgery
Equipment in general anaesthesia
Special monitoring
Depth-of-hypnosis monitoring has been developed to prevent awareness during
anaesthesia (Chikungwa and Smith 2003). Many devices are already in use and
several others are under development, but the bispectral index of EEG (BIS)
seems to be the most frequently used at the moment. The bispectral index is a
value derived from electroencephalography (EEG) (Sigl and Chamoun 1994).
A single number of BIS (ranging from 100 to 0) decreases when the depth of
anaesthesia increases. A BIS value < 60 is associated with “a very low probability
to recall” (Rosow and Manberg 2001). In ambulatory anaesthesia, the use of
a BIS monitor has resulted in faster emergence and decreased consumption of
propofol (Gan et al. 1997), sevoflurane and desflurane (Song et al. 1997). A wide
variation of BIS index levels has been used, but in studies concerning fast-
tracking, the BIS index levels have commonly been kept between 55-65 during
the maintenance of anaesthesia (Song et al. 1997; Tang et al. 2001) or a higher
level of BIS, 60-75, has been used towards the end of surgery (Gan et al. 1997).
Song and co-workers concluded that in outpatients, a BIS value as high as 75 at
the end of propofol or desflurane anaesthesia was needed to achieve faster PACU
discharge criteria and PACU bypass eligibility (Song et al. 1998).
Laryngeal mask airway versus intubation
A laryngeal mask airway (LMA) is used as often as a tracheal tube in elective ambu-
latory surgery (Joshi 2003). Since a LMA can be inserted without muscle relaxa-
tion or laryngoscopy, no neuromuscular reversal drugs are required at the end of
surgery. Most studies in patients breathing spontaneously through a laryngeal mask
have been done with sevoflurane or propofol. Also desflurane has been used with
LMA in patients breathing spontaneously (Tang et al. 2001; Dolk et al. 2002).
Anaesthetic agents used in general anaesthesia for ambulatory surgery
Propofol has a fast recovery profile, making it the hypnotic drug of choice for
induction of anaesthesia in outpatients. As a non-irritant volatile anaesthetic,
sevoflurane allows also rapid and smooth induction and can be used as an alterna-
tive to i.v. propofol/muscle relaxant induction (Joshi 2003). GA maintained
with propofol is associated with a lower incidence of PONV (Sneyd et al. 1998)
but a longer time to early stage recovery compared to anaesthesia maintained
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with desflurane or sevoflurane (Dolk et al. 2002). The highest fast-tracking per-
centages were obtained with desflurane compared with sevoflurane and propofol
(90% versus 75% and 26%) after gynaecological laparoscopy (Song et al. 1998).
The maintenance of anaesthesia with a modern, short-acting i.v. anaesthetic agent
(propofol) (Erhan et al. 2003) or inhaled anaesthetics (desflurane and sevoflu-
rane) renders recovery and home discharge times comparable to those after RA
(Li et al. 2000; Lennox et al. 2002b).
Opioids
Analgesia during surgery is mainly produced with opioids (White 2002). The
use of high doses of perioperative opioids increases the risk of complications, like
PONV, sedation, ventilatory depression and delayed home discharge (White 2002).
Fentanyl is a common opioid in ambulatory surgery and during MAC. With low
doses, 25-100 µg i.v., cumulation is not a problem, and recovery is not delayed.
Fentanyl is also suitable for postoperative use in the PACU as a rescue medication
(Tesniere and Servin 2003). Compared to fentanyl, alfentanil has a faster onset of
action (time to peak effect 4 min versus 1.5 min, respectively). In outpatients, the
incidence of PONV was lower after alfentanil than after fentanyl (Langevin et al.
1999). Remifentanil is an ultra-short-acting opioid having a similar onset as al-
fentanil, but a very short context-sensitive half-life that does not depend on the
duration of remifentanil infusion. It lacks the residual opioid effect, which has to
be remembered when planning the postoperative pain management (Tesniere
and Servin 2003).
Neuromuscular blocking agents
In ambulatory surgery, the neuromuscular blocking agents should have a short
duration of action (Schlaich et al. 2000). Mivacurium is a short-acting non-de-
polarizing muscle relaxant, providing rapid spontaneous recovery from neuromus-
cular block. Rocuronium at a dose of 0.6 mg/kg, is an intermediate-acting relax-
ant which provides a faster onset of action than mivacurium (Tang et al. 1996).
By reducing the dose of rocuronium to 0.45 mg/kg the onset time was pro-
longed by 60 s compared to a dose of 0.6 mg /kg (P<0.05), but the intubating
conditions remained excellent to good in 29 out of 30 patients. The duration to
reach a train-of-four (TOF) ratio 0.8 decreased from 60 to 45 min (NS), with the
reduced dose (Schlaich et al. 2000). To decrease the risk of residual muscle relax-
ation, objective neuromuscular monitoring should be used when administering
non-depolarizing muscle relaxants (Gätke et al. 2002; Eriksson 2003). Earlier, a
TOF ratio <0.7 (<0.8) was considered as an indication of residual paralysis (Gätke
et al. 2002; Eriksson 2003). However, since the patient’s ability to protect the
airways (an important factor when considering postoperative pulmonary compli-
cations) has been shown to diminish when the TOF ratio is <0.9, the safety limit
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of residual muscle paralysis has been set to a TOF ratio ≥ 0.9 (Eriksson 2003).
In day-surgery, the fast recovery of muscle relaxation, and thus the possibility to
avoid neuromuscular blocking reversal agents, is beneficial when considering the
possibility of PONV induced by the reversal drugs (Tang et al. 1996).
Side effects after general anaesthesia
Postoperative pain
Postoperative pain is often the reason for delayed home readiness and unplanned
hospital admission (Chung and Mezei 1999; White 2002). A balanced or multi-
modal technique (smaller doses of opioids in combination with local anaesthet-
ics and nonsteroidal anti-inflammatory drugs, NSAID) can provide effective pain
relief throughout the perioperative period, decrease the adverse effects of opioids
and thus, enable fast-tracking and earlier discharge home (White 2002). In a
systematic review, the use of i.a. local anaesthetic (bupivacaine) after knee arthros-
copy was shown to be effective in controlling pain during the first 1-4 postoper-
ative hours (Moiniche et al. 1999). In another systematic review, it was conclud-
ed that i.a. morphine at a dose of 5 mg achieved postoperative pain relief for up
to 24 hours after knee arthroscopy (Kalso et al. 2002).
Postoperative nausea and vomiting
The incidence of postoperative nausea and vomiting (PONV) after general anaes-
thesia is 30% (Kovac 2000) and PONV is associated with delayed home discharge
(Gold et al. 1989; Chung and Mezei 1999). It seems to be cost-effective to
recognise the patients at high PONV risk and to provide prophylaxis to them
(Watcha and Smith 1994; Apfel et al. 2004). A simplified risk score for PONV,
consisting of female sex, history of PONV or motion sickness, non-smoker, and
the use of postoperative opioids (Apfel et al. 1999) was developed to guide the
management of PONV. Several drugs, like traditional metoclopramide and droperi-
dol (Jokela and Koivuranta 1999; Henzi et al. 2000; Jokela et al. 2002), 5-HT3
receptor antagonists (Jokela and Koivuranta 1999; Jokela et al. 2000; Jokela et
al. 2002) and, dexamethasone (Henzi et al. 2000) have been studied, either alone
or in combinations, to prevent PONV.
A recent multicentre trial of 5199 patients, with factorial design (Apfel et al.
2004) showed a similar efficacy for each of the three antiemetics, i.e. droperidol,
dexamethasone and 5-HT3 receptor antagonists, in preventing PONV. No dou-
ble prophylaxis was superior to any other combination in preventing PONV. The
patients with a low/moderate risk for PONV can be anaesthetised by using either
a volatile anaesthetic together with antiemetic prophylaxis, or with propofol with-
out the prophylaxis. For the patients at high risk (>40%), a multimodal approach
(propofol maintained anaesthesia, with double antiemetic prophylaxis with droperi-
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dol, dexamethasone) should be chosen. The best cost-benefit choice is to use
droperidol and dexamethasone in prophylaxis and reserve the 5-HT3 receptor
antagonists for rescue medication (Apfel et al. 2004). On the other hand, the use
of droperidol became troublesome after the FDA (United States Food and Drug
Administration) “black-box” warning in 2001 indicating the possible associa-
tion with torsades des pointes ECG changes. It has not been shown, however,
whether the antiemetic doses prolong the QT-time, leading to this situation
(Dershwitz 2002). Furthermore, the delay in recovery when using a dose of 0.014
mg/kg of droperidol should be taken into consideration (Valanne and Korttila
1985).
Studies comparing spinal anaesthesia and general
anaesthesia in outpatients
SA and GA are both useful methods for ambulatory knee arthroscopy patients
with respect to patient safety and operating conditions. Patient satisfaction with
a certain technique may be related to the control of side effects, which have been
discussed earlier. The total cost of an anaesthetic method is more difficult to
evaluate. When only the costs of the drugs and disposables were calculated, the
perioperative costs were lower after lidocaine SA than after propofol-maintained
GA, USD 6.5 versus USD 30, respectively (Dahl et al. 1997). Although the time
after surgery to readiness to leave the OR has been shown to be shorter after SA
(lidocaine) than after GA (propofol or isoflurane), the preparation time corre-
sponded conversely, and home-readiness was equal (Dahl et al. 1997; Wong et al.
2001). In a study with low-dose SA (lidocaine and fentanyl) and propofol-main-
tained GA, the patient satisfaction, intraoperative and postoperative efficiency, as
well as discharge were comparable (Ben-David et al. 2001). Only a few studies
comparing ambulatory SA with bupivacaine to GA in patients undergoing knee
arthroscopy have been conducted. SA with 10 mg of bupivacaine resulted in
prolonged time to home-readiness compared with intravenous anaesthesia with
propofol and remifentanil (Danelli et al. 2002). On the other hand, 6 mg of
bupivacaine together with 15 µg of fentanyl i.t. resulted in equal home discharge
time compared with GA maintained with propofol (129 versus 131 min, respec-
tively) (Jankowski et al. 2003). Not only the drugs during anaesthesia, but also
the different times of recovery, as well as the costs of treating or preventing side
effects (pain, PONV, PDPH) should be taken into consideration when cost is
being evaluated (Dahl et al. 1997). In one recent study, these were evaluated after
SSA (lidocaine and sufentanil) and after GA (desflurane) in gynaecological pa-
tients. The mean cost of the drugs and disposals and nursing was significantly
lower after SSA than GA, whereas the costs of preparation and recovery were
equal. The number of patients in this study was, however, relatively low (i.e. 20)
(Lennox et al. 2002a).
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Aims of the
Study
The purpose of the thesis was to study the best possible anaesthesia for outpa-
tients undergoing knee arthroscopy, with special reference to reliability, recovery
times, side effects and the use of hospital facilities. The specific aims of the present
series of studies were:
1. To compare the quality of spinal anaesthesia and the time to home-readi-
ness after selective spinal anaesthesia produced by different doses of in-
trathecal hyperbaric bupivacaine with (II, III) or without low-dose fenta-
nyl (I, II, IV, V) and after general anaesthesia maintained with desflurane
(V).
2. To evaluate the possibility of a shorter stay in the post anaesthesia care unit
(PACU), or bypassing PACU altogether after spinal anaesthesia when us-
ing intrathecal hyperbaric bupivacaine alone (I, II, IV, V) or in combina-
tion with fentanyl (II, III) and after general anaesthesia maintained with
desflurane (V).
3. To evaluate the spread of spinal block after different doses of bupivacaine
alone or in combination with fentanyl (I-IV), as well as the effect of the
injection site (L2/3 or L3/4) and the posture of the vertebral column on
selective spinal anaesthesia (IV).
4. To compare the side effects after selective spinal anaesthesia with bupi-
vacaine, or a combination of bupivacaine and fentanyl (II, III, V), and
after general anaesthesia maintained with desflurane (V), and furthermore,
to find out whether intravenously administrated ondansetron can prevent
low-dose intrathecal fentanyl-induced pruritus compared to placebo (III).
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Patients and
Methods
Ethical aspects and patients
All studies were approved by the Ethics Committee of Lapland Central Hospital.
Studies III-V were also approved by the National Agency for Medicines. The
written informed consent of all patients was obtained. In total, 483 ASA I-III
ambulatory knee arthroscopy patients were investigated in 5 separate studies.
The studies were conducted during the years 2000-2003 in Lapland Central
Hospital, Rovaniemi, Finland.
Design of the original studies
Studies I-V were all prospective, controlled and randomised; Studies I-IV were
also double-blinded. A placebo-control was used in Study III. A sealed envelope
technique, with computer-generated random numbers was used to randomise
the patients. The study designs are given in Table 4.
Table 4. Study designs.
I II III IV V
Number of patients 106 100 90 123 64
Study design prospective, prospective,   prospective, prospective, prospective,
randomized, randomized, randomized, randomized, randomized
double-blind double-blind double-blind, double-blind
placebo-controlled
Bupivacaine mg 4 or 6 4 alone or 3 3 4 4
Dose of fentanyl µg 0 10 10 0 0
Vertebral interspace L2/3 L2/3 L2/3 L2/3, L3/4 L2/3
Intervention group bupivacaine 4 mg bupivacaine 3 mg ondansetron injection site L3/4 GA with
i.t.  + fentanyl 10 µg 4 or 8 mg i.v. with/without a desflurane
i.t. 5 degree head
down tilt
Control group bupivacaine bupivacine placebo i.v. injection site L2/3, SSA with
6 mg i.t. 4 mg i.t. horizontal 4 mg
Primary endpoint home readiness home readiness incidence produce SSA at L3/4 home
of pruritus level with/ without readiness
head down tilt and time in
of the vertebral PACU
column
SSA = selective spinal anaesthesia, PACU =  postanaesthesia care unit
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Methods
Premedication and monitoring
Before their arrival to the operating room, the patients received either ketoprofen
100 mg p.o. (I), nimesulid 100 mg p.o. (II) or ibuprofen 600 mg p.o. (Studies
III-V), or if contraindicated: paracetamol 1000 mg p.o. Intraoperatively, the
patients who had SA were given midazolam up to 2 mg i.v. and/or alfentanil up
to 0.5 mg (Studies IV-V) and up to 1 mg (Studies I-III) i.v. if needed. An
intravenous infusion of 0.9% saline was started before the lumbar puncture or the
induction of general anaesthesia. Standard monitoring (ECG, NIBP and pulse
oximetry) was used for all of the patients. Bradycardia was treated with glycopyr-
rolate (<50 beats per minute) and with atropine (<40 b.p.m) and hypotension
(<90 mmHg or SAP falling more than 50 mmHg from the baseline) was treated
with etilephrine i.v. Furthermore, the BIS-index, the adductor pollicis TOF ratio
(by using kinemyographic measurement with Datex-Ohmeda MechanoSensor®),
the inspired and end-tidal concentrations of oxygen, CO2, desflurane and N2O
were also monitored in the GA group. A tourniquet around the thigh, inflated
300-350 mmHg, was used in the operative extremity.
Spinal anaesthesia
In Studies II-V, a spirit level was used before the spinal puncture to ensure that
the posture of the vertebral column was horizontal (in Studies II-V) or tilted 5
degrees “head down” (in Study IV, in the group L3/4T). In Studies I-III and in
the spinal group in Study V, the injection site was L2/3. In Study IV, one third
of the patients were injected at the L2/3 interspace, with the vertebral column
horizontal (control group), one third at the L3/4 interspace, with the vertebral
column tilted 5 degrees head down, and one third at the L3/4 interspace with
the vertebral column horizontal. Technically, the spirit level was placed along the
lower thoracal and all lumbar spinosus processes while the patient was lying side-
ways, the operative side dependent. After that the inclination of the vertebral
column was set to 0 or 5 degrees head down tilted, depending on the study
group, by turning the operating table to a proper position.
The dural puncture was performed with a 27-G Quincke needle (Becton-
Dickinson Yale Spinal®) either with a median or lateral approach with or without
an introducer. At the time of injection, the patient was in a lateral decubitus
position, the operative side dependent: the position was maintained for 10 min
from the beginning of the injection, in all studies. At 7 min, an additional head
down or head up tilt was used for 3 min, if the sensory block was inadequate (i.e.
the upper level of the sensory block was < L1 or the lower level was > L5).
Hyperbaric 5 mg/ml bupivacaine (Marcain® spinal tung, Astrazeneca) was
used in all studies, either alone or in combination with fentanyl (Fentanyl B.
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Brown 50 µg/ml, Brown Medical). In Study I, either 4 mg (0.8 ml) or 6 mg
(1.2ml) of hyperbaric bupivacaine was injected i.t. In Study II, the study drug
was either 4 mg of hyperbaric bupivacaine or 3 mg of bupivacaine in combina-
tion with 10 µg of fentanyl (the volume of both solutions was 0.8 ml). In Study
III, all the patients received a combination of 3 mg of bupivacaine and 10 µg of
fentanyl (0.8 ml). In Studies IV and V the dose of bupivacaine was 4 mg (0.8
ml). The study drug was injected over a 2-min period (i.e. 0.4 ml/min, except
the patients receiving 6 mg in Study I, the rate was 0.6ml/min) in the studies.
The aperture of the needle was turned laterally towards the nerve roots involved.
To ensure good needle placement, a gentle aspiration of 0.1 ml was used. A 1-ml
syringe (divided into 0.1-ml sections) was used in Studies II-V.
The specific gravities (= the ratio of the density of the solution at a specified
temperature to the density of water at the same temperature) of 5 mg/ml Mar-
cain® spinal tung and the solution (0.6 ml of hyperbaric bupivacaine and 0.2 ml
of fentanyl) used in Studies II-III, were calculated by the pharmacists of the
Lapland Central Hospital. The specific gravity of the commercial 5 mg/ml bupi-
vacaine glucose mixture, Marcain® spinal tung was measured to have a specific
gravity of 1.031 at 20°C (according to Pharmaca Fennica, the specific gravity of
the Marcain® spinal tung is 1.026 at 20°C) and the specific gravity of the solu-
tion containing Marcain® spinal tung and fentanyl (3:1) was measured to have a
specific gravity of 1.026 at 20°C, being thus hyperbaric relative to the CSF.
Evaluation of the sensory, sacral and motor blocks
The sensory block of the thoracic and lumbar nerves as well as the first sacral
nerve (S1, measured form the little toe) was recorded on each side by using cold
stimulus (acetone drop) to the respective dermatomes at 7, 12 and 30 min after
the beginning of the injection, at the end of the operation, and every 20 min
thereafter until recovery of dermatome L2 or discharge home. At 30 min, S1 was
not tested because of existing surgical drapes at that time. If the dermatomes L1-
L5, (L1 – L4 in studies I-II) on the operative side were not blocked at 12 min,
the block was considered to have failed, and the patient received a general anaes-
thesia. The motor block on each side was assessed according to a modified Brom-
age scale (Kuusniemi et al. 1999) at 12-15 min after the beginning of the injec-
tion, postoperatively, and every 20 min thereafter, until complete recovery. Five
myotomes were tested: L2 = hip flexion, L3 = knee extension, L4 = ankle dorsi-
flexion, L5 = great toe dorsiflexion, S1 = ankle plantar flexion. The score of each
myotome was recorded as no block = 0 or complete block =1 point. Both sides
were tested separately, and the maximum score on each side was 5 out of 5 points.
P A T I E N T S  A N D  M E T H O D S 35
General anaesthesia
In Study V, half of the patients received general anaesthesia (GA). The risk of
postoperative nausea and vomiting (PONV) was assessed, and the patients with
≥2 risk factors (female, non-smoker, history of PONV or motion sickness) were
given prophylactic dexamethasone 5 mg i.v. after induction and a 5-HT3 antago-
nist (ondansetron 4 mg) i.v. at the end of surgery. Rescue medication for PONV
was provided by metoclopramide 10 mg i.v. for the patient who had received the
prophylaxis, and ondansetron 4 mg i.v. for the patient without prophylaxis. GA
was induced with propofol 2-3 mg/kg, 0.1 mg fentanyl and rocuronium 0.4
mg/kg i.v. Anaesthesia was maintained with desflurane 2-6% and 50% N2O in O2
titrated to keep the BIS index value towards the end of the operation between 50
and 60. For the first 6 min after intubation, a high-flow of 5 L/min of fresh gas
was used, followed by a low-flow of 0.7 L/min for the rest of the anaesthesia.
Additional fentanyl 0.05 mg i.v. was allowed when clinically indicated (blood
pressure or heart rate more than 15% above the baseline values). All patients were
mechanically ventilated to maintain an end-tidal CO2 concentration of 4.5–5.5
kPa. A bolus dose of rocuronium (0.1mg/kg i.v.) was administered if required
(high peak inspiratory pressure values or coughing). Neuromuscular reversal drug
was used if the TOF ratio was less than 0.8 at the end of the operation. When the
tourniquet was released, desflurane and N2O were discontinued. The patients
were extubated when fully awake.
Criteria for fast-tracking, PACU discharge and home-
discharge
The time in the postanaesthesia care unit (PACU) was recorded as the time from
admission to the PACU until transfer to the ambulatory surgery unit (ASU).
After SSA, the criteria to transfer to ASU were full recovery from motor block,
sensory block not above Th12, and stable vital signs. If the criteria mentioned
above were fulfilled at the end of the operation, the patient bypassed PACU (i.e.
was fast-tracked). After the release of the tourniquet, and every 20 min thereafter,
the sensory and motor blocks were evaluated until the transfer to the ambulatory
surgery unit (ASU). In Study V, after SSA the PACU discharge was evaluated by
using both the new fast-tracking scoring system (White and Song 1999) and
furthermore, complete recovery from motor block, sensory block not above Th12,
and ability to sit up. The patient was fast-tracked to ASU, if the latter criteria
were fulfilled at the end of surgery, considering that the new fast-tracking criteria
were fulfilled, too. In the GA group, the recovery status was assessed after extuba-
tion and every 20 min thereafter by using the new fast-track scoring system (White
and Song 1999). A minimum score of 12 out of 14 with no zero scores was
required for the patient to be fast-tracked. Before transferring to ASU the patient
had to be able to sit up, and patients with vertigo, somnolence, or those who
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wanted to lie down, were kept in the PACU, even though their fast-tracking
score was ≥12.
The home-discharge criteria consisted of: stabile vital signs, absence of PONV,
no or minimal pain (VAS < 4), no bleeding, and ability to walk. A physiotherapist
tested the ability to stand and ambulate, and gave the training instructions to the
patients in the ASU. Voiding was required before home-discharge in Studies I-IV.
The times of walking, voiding and home-readiness were measured from the time of
spinal injection, in Studies I-IV. In Study V, voiding was not required before home-
readiness, but the time to void was recorded if the patient had not yet left the
hospital (for example no escort arrived). The times of walking and home-readiness
were measured from the time of releasing the tourniquet (Study V).
In Study V, the anaesthesia preparation time (APT) was recorded as the time
from ensuring the posture of the vertebral column until the end of the 10 min
required for the patient to maintain the lateral decubitus position, in the SSA
group. In the GA group, the APT was considered as the time from the begin-
ning of injection of the induction drugs until connection of the patient to
a respirator. Immediate recovery time from anaesthesia was recorded as the time
from release of the tourniquet until extubation and orientation. The APT
together with the immediate recovery time were considered as the anaesthesia-
related time.
Postoperative follow-up and patient satisfaction
In the PACU and ASU, symptoms like PONV and pain were recorded in all
studies. Pruritus was evaluated in Studies II and III. Home-readiness was assessed
as described above. Postoperative pain was evaluated with a verbal analogue scale
(VeAS) from 0 = no pain to 10 = the worst pain imaginable (Ben-David et al.
2001) or with a visual analogue scale (VAS) from 0 = no pain to 10 = the worst
pain imaginable. Severe postoperative pain (VeAS or VAS >7) was treated with
fentanyl i.v. (up to 0.1 mg), and moderate pain (3< VeAS/VAS<8) with a combi-
nation of paracetamol and codein (1g of paracetamol and 60 mg of codein) p.o.,
or if contraindicated, with tramadol (100 mg) i.v./p.o. Mild pain (VeAS/VAS <4)
was treated with ketoprofen (50 mg) i.v. or propacetamol (2 g) i.v. If the pain relief
was still insufficient, the patients received i.v. oxycodone (3-5 mg i.v. repeatedly
until the pain relieved) and were admitted to the hospital. In Studies II and III, the
pruritus was treated with naloxone 0.004–0.01 mg i.v., when needed.
A telephone interview was conducted within 4-7 days to elucidate the side
effects and patient satisfaction. In Studies I-IV the interviewer was blinded to the
method used. The patients were asked about headache (positional headache was
considered as postdural puncture headache, PDPH), backache, TNS, difficulties
in voiding, pain and post-discharge nausea or vomiting. TNS was defined as pain
radiating to the buttocks or legs and/or sensory disturbances in areas not related
to the surgery. In Studies II and V, the pain in the operated knee was asked by
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using a verbal analogue scale from 0 to 10. In Study II, the pruritus was evaluat-
ed on a scale of mild, moderate or severe in the hospital, and in Study III, by
using a verbal analogue scale (from 0 = no pruritus to 10 = the worst pruritus
imaginable) in the hospital and at home.
The patient’s opinion of the anaesthesia given was asked by using the alterna-
tives superior, equal or worse than anticipated. Their willingness to choose the
same type of anaesthesia for a similar operation in future was also asked.
Statistical analysis
For all studies, a power-analysis was performed with a power of 0.80 and a signif-
icance level of 0.05. In Studies I-II, the sample sizes (of 52 and 44, respectively)
were calculated to detect a 25% reduction in the time of recovery from motor
block after two different doses of i.t. anaesthetic drug (with 45% SD in Study I,
and 50 min SD in Study II). In Study III, the incidence of i.t. fentanyl-induced
pruritus was assumed to decrease 50% when using prophylactic ondansetron:
75% without and 37.5% with ondansetron. The sample size of 24 per treatment
group was raised to 30 because of possible dropouts. In Study IV, the level of
sensory block was assumed to reach 2 segments lower in 30% of the patients
when the i.t. drug was injected at the L3/4 interspace with a horizontal position
of the vertebral column compared to the sensory block in patients injected at the
L3/4 interspace with a 5 degree head down tilt of the vertebral column, or in
patients injected at L2/3 level with a horizontal position. The calculation result-
ed in a sample size of 36 patients per treatment group. In Study V, the sample
size of 28 per group was calculated to detect a 20% difference in home-readiness,
assuming the time to be 110 min and 140 min after SSA and GA maintained
with desflurane, respectively.
The Statistical Package for Social Sciences (SPSS®) for Windows (Versions
9.0, 10.0, 11.0.1 and 12.0) was used for statistics in all studies (SPSS Inc., Chi-
cago, IL, USA). The Confidence Interval (CI) analyses were performed with the
CIA program (Gardner and Altman 1989) in Studies III-IV to compare the
outcomes by calculating the 95% confidence interval for the differences in pro-
portions. When comparing categorical data, χ² and Fisher’s exact tests were used,
whereas for nonparametric data the tests were Kruskal-Wallis, Mann-Whitney U
and Student’s t-tests. A two-tailed P-value below 0.05 was considered as statisti-
cally significant in all studies.
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Results
Patients, failures and reliability
The number of patients and their characteristics in Studies I-V and within sub-
groups are given in Tables 5 and 6. Because of a failed block, 4 patients in Study
I, one patient in Study II, and 4 patients in Study III received GA for the surgical
procedure and these patients were excluded from all analyses. In Study IV, there
was one failure (2.5%) in the group L3/4T, 2 failures (5%) in the group L2/3
and 5 (12%) in the group L3/4H. These patients were included in the analyses of
both the sensory and motor block (in order to estimate the effects of using a
lower interspace on the level of the block), but were excluded from the analyses
Table 5. Number of patients in Studies I-V, within different subgroups, protocol violation and failures.
 I  II III   IV  V Total
B4 B6 B3F B4 O4 O8 P L2/3 L3/4T L3/4H SSA G A  SSA G A
Number of patients
– randomized 106 100 90 123 64 451 32
– protocol violation 3 0 1 0 0 1 0 3 1 0 0 0 9 0
or impossible
dural puncture
– total 103 99 89 119 64 442 32
– within groups 51 52 49 50 30 29 30 38 40 41 32 32
– failures 3 1 1 0 2 2 0 2 1 5 2 0 19 0
(6) (2) (2) (6.7) (6.9) (5.3) (2.5) (12.2) (6.3) (4.3)
– final within groups 48 51 48 50 28 27 30 36 39 36 30 32 423 32
Values are n (%).
Table 6. Patient characteristics in Studies I-V.
I II III IV V
Number of patients 99 98 85 111 62
Gender; female/male 46/53 51/47 36/49 52/67 29/33
Age (years) 45±15 43±14 47±15 45±14 42±14
46 [15-82] 45 [18-73] 47 [19-76] 46 [19-73] 43 [19-76]
BMI (kg/m2) 26±3 26±4 26±3 26±3 26±3
25 [18-32] 25 [19-33] 26 [18-34] 26 [18-33] 26 [18-32]
Duration of 26±11 29±17 33±15 29±15 33±21
surgery (min) 23 [8-62] 24 [7-80] 30 [9-75] 26 [4-92] 26 [8-114]
Duration of  anaesthesia
at the end of 62±13 62±18 67±15 66±16 71±21
surgery (min) 60 [33-105] 58 [37-120] 65 [39-111] 63 [38-26] 69 [40-134]
BMI = body mass index = weight kg/ (height m²); values are mean ±SD or median [range].
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concerning the time in PACU and home discharge, because they received general
anaesthesia for the operation. In Study V, in the spinal group 2 failures (6%)
resulted in exclusion. In the GA group, 3 patients had to stay overnight in hos-
pital, and were excluded from the analyses concerning ambulating, voiding and
home-discharge. The overall incidence of failure was 4% (19 patients) after SSA.
The final number of patients receiving successful SSA was 423, and 32 patients
were randomized to receive GA (Study V).
The quality of the anaesthesia is shown in Table 7. One patient in Studies I
and V, and 4 patients in Study III received also propofol. One patient felt anx-
ious already before the operation started, 5 others felt pain or discomfort during
the procedure, and they received propofol aproximatley 45 min after the spinal
injection. In 4 out of 6 cases, the injection had been technically difficult. In all
studies, the three most common arthroscopic procedures (involving 63-95% of
the patients) were partial excision of meniscus, operation for osteochondritis and
exploration of the knee joint. The surgeon evaluated the quality of motor block
to be good or satisfactory in 86 %, 98 % and 97 % of the patients after i.t. bupi-
vacaine 3 mg + fentanyl 10 µg, bupivacaine 4 mg and general anaesthesia, respec-
tively. The number of the patients with unilateral motor, sensory and sacral seg-
ment block, or no sacral (S1) block at all is given in Table 7.
Table 7. The quality of the anaesthesia.
I II III IV V
B4 B6 B3F B4 O4 O8 P L2/3 L3/4T L3/4H SSA GA
Number of
patients 51 52 49 50 30 29 30 38 40 41 32 32
Failed block 3 1 1 0 2 2 0 2 1 5 2 N.A.
(5.9) (1.9) (2) (0) (6.7) (6.9) (0) (5.3) (2.5) (12.2) (6.3) N.A.
Additional opioids 2 1 5 7 7 6 6 5 5 4 3 24
during surgery (4) (2) (10) (14) (24) (23) (20) (14) (13) (11) (10) (75)
Quality of motor block1
good/ N.A. N.A. 36/ 43/ 22/ 13/ 19/ 34/ 36/ 29/ 27/ 30/
satisfactory/poor 8/4 5/2 1/4 7/6 5/4 –/– –/1 4/1 1/0 1/1
Motor block 48 44 26 24 30 34 34 33 N.A. N.A.
unilateral (100) (88) (93) (89) (100) (94) (87) (92)
Sensory block 10 4 7 11 8 4 7 15 7 11
unilateral (21) (8) (15) (22) (29) (15) (23) (42) (18) (31)
Sacral (S1) block 38 41 17 24 24 30 26 27
unilateral (79) (82) (61) (89) (80) (83) (67) (75)
No S1 block at all 3(6) 5(10) 2(7) 0 3(10) 1(3) 4(10) 0
Values are n (%). S1 = sacral segment block. 1Asessed by the surgeon.
40 R E S U L T S
Sensory block and sacral segment block
In Study I, comparison of two doses, 4 and 6 mg of 5mg/ml hyperbaric bupi-
vacaine injected at the L2/3 interspace, showed a significant difference in the
upper level of the sensory block between the groups (Figure 1). On the operative
side, the highest level of sensory block was seen 30 min after the injection, reach-
ing Th7 (median) compared to Th10 after the 6 mg and 4 mg doses of bupi-
vacaine, respectively. The sensory block was lower, but adequate, on the operative
side after the 4 mg dose compared to 6 mg. The extension of sensory block
decreased to L2 or lower after 120 versus 160 min after the 4 mg and 6 mg dose,
respectively.
In Study II, the comparison of a 4 mg dose of hyperbaric bupivacaine to 3
mg of hyperbaric bupivacaine combined with 10 µg of fentanyl injected at the
L2/3 interspace, gave no statistical difference in the development or recovery of
sensory block. On the operative side, the sensory block reached the Th10 (medi-
an) after 4 mg of bupivacaine and Th11 after the combination at 30 min, and
decreased to L1 level or lower after 120 min in both groups (Figure 1).
In Study III, all the patients received 3 mg of bupivacaine combined with 10 µg
of fentanyl intrathecally. The upper sensory block reached the Th11 (median) der-
matomy at 30 min, and the block faded to L2 level or below in 120 min (Figure 1).
In Study IV, the median level of the upper sensory block was significantly
higher when the spinal drug was injected at the L3/4 interspace with the verte-
bral column tilted head down (L3/4T) compared to an injection at L2/3 (L2/
3) or L3/4 (L3/4H) interspace with the vertebral column kept horizontal. At
30 min, the median upper level of the sensory block was Th8, Th10 and Th11 in
the groups L3/4T, L2/3 and L3/4H, respectively (Figure 2). To achieve an
adequate level of sensory block, 26% and 39% of the patients needed a modifica-
tion of the posture (i.e. an additional head down tilt of the operation table for 3
min), in the groups L2/3 and L3/4H (NS), respectively. After this change in
posture, 5% and 12% of the patients still had inadequate block for surgery (=
failed block). On the other hand, when the same dose was injected at the L3/4
interspace tilting the vertebral column 5 degrees head down during the time of
injection (up to 6 min), only 10% of these patients needed postural modification,
and finally only 2.5% of the blocks failed.
When the L2/3 interspace and a horizontal position was used, an additional
head down tilt at 7 min was needed in 16-25% of the patients after 4 mg of
bupivacaine (Studies I-II), in 14% of the patients after 6 mg of bupivacaine (Study
I) and in 23% of the patients with the combination of bupivacaine and fentanyl
(3 mg + 10µg) (Study II).
The number of patients having unilateral sacral segment (S1) block or no sacral
segment block on either side is given in Table 7. The 4 mg dose of bupivacaine
and the combination (bupivacaine and fentanyl), produced either a unilateral or
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*P=0.017 
*P=0.008 
#P<0.001 
#P<0.001 
#P=0.004 
Figure 1. The median of the upper level of the sensory block at the operative side at different
times and after different doses of hyperbaric bupivacaine or bupivacaine + fentanyl combination.
Figure 2. The median of the upper level of the sensory block at the operative side at different
times with 4 mg of bupivacaine, after a different injection site and position of the vertebral
column.
B3FII/III = Bupivacaine 3 mg + fentanyl 10 µg in Studies II and III. B4II = Bupivacaine 4
mg in Study II, B4I = bupivacaine 4 mg in Study I and B6I = bupivacaine 6 mg in Study I.
*P < 0.01 between groups B6I and B4I, **P < 0.001 between groups B6I and B4I. EO=
end of operation.
L2/3 = Injected at L2/3 level, with the vertebral column horizontal, L3/4T= injected at
L3/4 level with the vertebral column tilted 5 degrees head down, L3/4H= injected at L3/4
level with the vertebral column horizontal. EO= end of operation.
*P values are between groups L2/3 and L3/4T and,
# P values are between groups L3/4H and L3/4T.
*
*
**
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an unaffected (i.e. the S1 not blocked on either side) sacral block to >75% of the
patients when injected at L2/3 interspace. When the L3/4 level was used with-
out a tilt, 75% of the patients had unilateral S1 block, but no one had an unaf-
fected S1 block, whereas with the head down tilt 10% of the patients did not
develop S1 block on either side. A significantly greater number of patients had S1
blocked at different time points in the L3/4 horizontal versus L3/4 tilt group
(Figure 3).
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Figure 3. The proportions of patients having sacral segment (S1) block at different times on
the operative side after spinal injection of 4 mg of hyperbaric bupivacaine.
The P values shown are between the groups L3/4T (T=vertebral column tilted head down
for 6 min) and L3/4H (H= horizontal position). EO= end of operation.
Combining all the studies, the upper sensory level was equal after a 4 mg dose of
bupivacaine injected at L2/3 interspace in Studies I-II and IV, and after combi-
nation of 3 mg of bupivacaine and 10 µg of fentanyl injected at L2/3 interspace
in Studies II-III. On the other hand, the 6 mg dose injected at L2/3 interspace
resulted in a similar upper level of the sensory block as the 4 mg dose injected at
L3/4 level with the vertebral column 5 degrees tilted for the first 6 min. The
lower level of the sensory block, i.e. the sacral segment block was mostly unilater-
al with a 4 mg dose injected at L2/3 or L3/4 level with a horizontally posi-
tioned patient, whereas injection at the L3/4 level with a head down tilt of the
vertebral column left the sacral segments more often intact.
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Motor block
In Study I, the maximal motor block, median [range], on the operative side was
similar, 5 [1-5] and 5 [0-5] after 4 and 6 mg dose of bupivacaine, respectively. In
Study II, the motor block on the operative side was 3 [1-5] and 2 [0-5], P<0.01,
after 4 mg of bupivacaine and 3 mg of bupivacaine and 10 µg fentanyl, respec-
tively. The recovery from motor block happened in the following order: 3 mg of
bupivacaine + 10 µg fentanyl > 4 mg > 6 mg of bupivacaine, when injected at the
L2/3 interspace (Figure 4).
Figure 4. Cumulative percentages of patients needing 80 min, 120min, 160min, 200 min to
recover from motor block on the operative side after spinal anaesthesia with different doses
of bupivacaine or the combination of bupivacaine and fentanyl.
*P=0.01, **P<0.001, ***P=0.001 in Study I, between groups B4 and B6. #P=0.002,
##P=0.051 in Study II between groups B3F and B4. B4I=bupivacaine 4 mg in Study I,
B6I=bupivacaine 6 mg in Study I, B3FII= bupivacaine 3 mg +10 µg fentanyl in Study II,
B4II= bupivacaine 4 mg in Study II, B3FIII=all patients in Study III.
In Study IV, with the 4 mg dose of bupivacaine, the maximum motor block on
the operative side was equal, when injected either at L2/3 interspace with the
vertebral column horizontal or at L3/4 interspace with the vertebral column
horizontal or tilted head down. The motor recovery was similar between the
groups, and comparable to the recovery times after the 4 mg dose in Studies I-II.
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At 12 min, the myotomes L2 (hip flexion) and L3 (knee extension) were mostly
blocked, and the least affected was S1 (ankle plantar flexion), in all groups. The
myotome L5 (great toe dorsiflexion) was blocked in 60% of the patients with the
intrathecal injection at L3/4 level with the head down tilt versus in 88% of the
patients (P=0.005) with the intrathecal injection at the L3/4 interspace without
the tilt.
Combining Studies I-IV, the motor block (on a modified Bromage scale) was
equal 15 min after spinal injection when using either 6 or 4 mg of hyperbaric
bupivacaine, but a more profound motor block was seen after 4 mg of hyperbaric
bupivacaine compared to a combination of 3 mg of hyperbaric bupivacaine to-
gether with 10 µg of fentanyl. The maximal motor block or the time of recovery
from the motor block did not differ with the 4 mg dose of bupivacaine injected
either at L2/3 or L3/4 level with or without the head down tilt. However, more
selective motor block was seen when the injection site was at the L3/4 level with
the head down position. In Studies II-IV, the motor block was highly unilateral
in all groups (Table 7).
Haemodynamic changes
The number of patients with cardiovascular side effects is given in Table 8. The
overall incidence of hypotension was 3% (12/423) and bradycardia 10% (44/
423), after selective spinal anaesthesia. In Study V, none of the patients in the
spinal group needed treatment for hypotension versus 7 (22%) patients in the
general anaesthesia group (P=0.011), and 3 (10%) versus 8 (25%) received treat-
ment for bradycardia (NS). In Study IV, none of the patients in the L3/4 tilt
group needed treatment for cardiovascular side effects, although the upper level
of sensory block reached higher than in the horizontal groups.
Table 8. Cardiovascular side effects.
I II III IV V Total
B4 B6 B3F B4 O4 O8 P L2/3 L3/4T L3/4H SSA GA SSA
Hypotension 3 (6) 3 (6) 1 (2) 0 1 (4) 1 (4) 2 (7) 0 0 1 (3) 0 7 (22)* 12 (3)
etilefrine 3 (6) 3 (6) 1 (2) 1 (4) 1 (4) 2 (7) 1 (3) 7 (22)
Bradycardia 7 16 3 (6) 5 (10) 3 (11) 1 (4) 1 (3) 4 (11) 0 1 (3) 3 (10) 8 (25) 44 (10)
glycopyrrolate 6 (13) 12 (24) 2 (4) 3 (6) 1 (4) 1 (4) 0 3 (8) 1 (3) 7 (22)
atropine 1(2) 4 (8) 1(2) 3 (6) 2 (7) 0 1 (3) 1 (3) 1 (3) 2 (7) 1 (3)
Values are n (%). *P=0.011 between GA and SSA groups in Study V.
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Postoperative pain and PONV
In Study II, the postoperative pain at home was similar after spinal anaesthesia with
3 mg of bupivacaine and 10 µg of fentanyl (B3F) and after 4 mg of bupivacaine
(B4) (Table 9). The pain VeAS score was at its highest in the evening of the oper-
ating day: 3.7 versus 3.1 in the B3F and B4 groups (NS) respectively. In Study V,
the patients in the GA group had more pain in the hospital compared to the spinal
anaesthesia group. The median VAS score in PACU was 5 (0-10) after GA and
versus 0 (0-2) after SSA (P<0.001). At home, the pain was mild in both anaesthesia
groups. In Study V, 41% of the patients in the general anaesthesia group received
double PONV prophylaxis. In the hospital, the incidence of PONV was 19% com-
pared to 0% (P = 0.024) in the general anaesthesia and spinal anaesthesia groups,
respectively. At home, no difference was seen between the groups. In Studies II-IV,
no one had PONV in the hospital after spinal anaesthesia. In Study III, 65% of the
patients received ondansetron 4 or 8 mg i.v. before spinal anaesthesia.
Table 9. Postoperative pain and side effects.
I II III IV V Total
B4 B6 B3F B4 O4 O8 P L2/3 L3/4T L3/4H SSA GA SSA
Pain VAS in 0* 5
PACU [0-2] [0-10]
Pain VeAS at home 3.7 3.1 2 3
1st evening [0-10] [0-10] [0-8] [0-8]
PONV in N.A. N.A. 0 0 0 0 0 0 0 0 0** 6 0
hospital (19)
PONV at home 6 5 5 2 0 1 5 0 2 4
(13) (10) (18) (7) (3) (13) (7) (13)
PDPH 2 2 2 2 3 1 2 3 2 1 1 – 22
(4) (4) (4) (4) (10) (4) (7) (8) (5) (3) (3) (5)
Needed an epidural 0 0 0 1 1 1 0 0 0 0 1 – 4
blood patch (2) (3) (4) (3) (1)
TNS 1 2 3 0 0 1 0 1 1 1 1 2 11
(2) (4) (6) (4) (3) (3) (3) (3) (6) (3)
Backache 6 5 9 6 1 1 2 8 3 7 4**** 0 52
(13) (10) (19) (12) (4) (4) (7) (22) (8) (20) (14) (12)
Dysuria 0 1 1 0 2 0 2 1 2 0 0 1 10
(2) (2) (7) (7) (3) (5) (3) (2)
Pruritus N.A. N.A. 36# 2 21 19 17 N.A. N.A. N.A. N.A. N.A.
(75) (4) (75) (70) (57)
from mild to 32 2 18 15 13
moderate
severe 4 0 3 4 4
Somnolence in 0*** 9
ASU (28)
Values are median [range]; n (%).  #P<0.001 between B3F and B4 groups. *P<0.001, **P=0.024; ***P=0.002;
**** P=0.049 between SSA and GA groups.
VAS = visual analogue scale, VeAS = verbal analogue scale, PACU = postanaesthesia care unit, PONV = postoperative nausea
and vomiting, PDPH = postdural puncture headache, TNS = transient neurological symptoms, ASU = ambulatory surgery unit.
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Fast-tracking and time in PACU
We found no difference in the number of patients who were fast-tracked between
the groups in Studies II-V. In Study II, there was a trend towards a better possibil-
ity to bypass PACU with the combination of bupivacaine and fentanyl (3 mg + 10
µg) versus the 4 mg dose of bupivacaine: 35% versus 18% of the patients were fast-
tracked (P=0.068), respectively. Furthermore, the time in PACU was significantly
shorter with the combination (Table 10). When combining all the patients who
received an equal amount of local anaesthetic agent, fast-tracking was achieved in
35% (47/133) and 12% (23/199) of the patients with 3 mg of bupivacaine and 10
µg fentanyl (Studies II-III) and 4 mg of bupivacaine (Studies II, IV-V), respective-
ly. When SSA and GA were compared, no statistical difference was found in the
fast-tracking possibilities or in the PACU time. In the SSA group (V), 12 patients
were admitted to PACU instead of fast-tracking because of partial motor block on
the operative side, although the new fast-tracking criteria were fulfilled, and 14 SSA
patients stayed in PACU because of complete motor and/or sensory block above
Th12 on the operative side. If we had followed the new fast-tracking criteria (where
some weakness in the movement of the extremities is allowed if scores from the
other six categories are sufficient) also in the spinal group, 12 additional patients
with only partial motor block in the PACU could have been fast-tracked. Then 16
(53%) of the patients in the spinal anaesthesia group could have been fast-tracked
compared to 7 (22%) in the GA group (P=0.017).
Home-readiness
In Study I, the standard home discharge criteria were fulfilled significantly faster
after the use of 4 mg of hyperbaric bupivacine compared to 6 mg dose, after 181
min [115-319] and 209 min [147-377] (P<0.001), respectively (Table 10). In
Study II, using the combination of 3 mg of bupivacine and 10 µg of fentanyl did
not further shorten the time to home-readiness. In Study III, the home-readiness
was achieved after 175 min [94-304] with 3 mg of bupivacaine and 10 µg of
fentanyl.
In Study IV, the injection site (L2/3 or L3/4) or the posture of the vertebral
column (horizontal or tilted 5 degrees cranially) did not affect home-readiness,
but the overall recovery times were nevertheless longer than in the three earlier
and in the one later study. The median home-readiness time was 212 [141-333]
after injection at the L2/3 level, 197 min [131-243] at the L3/4 level with the
horizontal posture of the vertebral column and 194 min [142-280] at the L3/4
interspace with the vertebral column tilted cranially.
In Study V, voiding was no longer required before home discharge, but it
was recorded if the patient was still in hospital. When home readiness was adjust-
ed from the time of induction or injection, the patients were home ready 192
min after GA and 183 min after spinal anaesthesia (NS).
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Side effects at home
The side effects are given in Table 9. The overall incidence of postdural puncture
headache (PDPH) was 5% (22 patients), and 1% (4 patients) of the patients need-
ed an epidural blood patch. 3 % of the patients (11/423) developed transient
neurological symptoms after spinal anaesthesia and 6% (2 patients) after general
anaesthesia. After spinal anaesthesia (all study groups), 2% of the patients devel-
oped some difficulties in voiding, but none of them needed medical help. The
incidence of dysuria at home was 3%, in the patients undergoing general anaesthe-
sia. In Study II, the incidence of pruritus was 75% after i.t. bupivacaine (3 mg)
combined with 10 µg of fentanyl and 4% (P<0.001) after 4 mg dose of i.t. bupi-
vacaine. 63 % of the patients considered the pruritus to be mild in the bupivacaine-
fentanyl group. In Study III, all the patients received 3 mg of bupivacaine and 10
µg of fentanyl i.t.. Compared to placebo, the incidence of pruritus was equal to
that after prophylactic i.v. ondansetron 4 or 8 mg, 57-75% of the patients devel-
oped pruritus. The median duration of the pruritus was 0.5-2.0 hours.
Patients’ experience and satisfaction
The overall satisfaction with the anaesthesia was high (Table 11). The anaesthesia
experience was judged to be equal or superior to expectations in 89-100% and
97% of the patients after SSA or GA, respectively. Similarly, 92–100 % and 78% of
Table 10. The time in PACU and until fulfilment of home discharge criteria after selective spinal and general anaesthesia.
I II III IV V
B4 B6 B3F B4 O4 O8 P L2/3 L3/4T L3/4H SSA GA
Time in PACU 64* 94 36** 55 21 24 20 48 45 44 40 30
[21- [30- [10- [10- [0- [0- [0- [0- [6- [3- [0- [0-
122] 202] 103] 140] 93] 135] 60] 130] 95] 93] 105] 147]
Ambulating 166* 196 158 166 147 152 151 195 186 179 180 175
[101- [139- [87- [111- [103- [84- [100- [136- [125- [121- [110- [80-
246] 367] 274] 269] 224] 238] 265] 253] 260] 238] 240] 319]
Voiding 172* 203 171 182 155 187 168 205 186 195 185 203
[115- [122- [99- [111- [103- [94- [103- [125- [124- [126- [115- [108-
319] 377] 395] 311] 256] 252] 304] 285] 278] 243] 280] 319]
Home-readiness; 181* 209 171 183 172 190 168 212 194 197 183 192
from the time of [115- [147- [111- [111- [103- [94- [103- [141- [142- [131- [115- [83-
injection/ 319] 377] 279] 316] 256] 266] 304] 333] 280] 243] 245] 319]
induction
Times are minutes; median [range]. PACU= postanaesthesia care unit. *P<0.001 bupivacaine 4 mg versus 6 mg.
**P=0.005 combination of bupivacaine 3 mg and fentanyl 10 µg versus bupivacaine 4 mg.
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the patients in the SSA and GA groups would choose the same anaesthesia also
the next time.
In Study V, the patients’ experience of the anaesthesia was mostly superior to
their expectations in both groups, and they would choose the same anaesthesia
technique also in future. Although not statistically different, a higher number of
the patients in the GA group would prefer spinal anaesthesia the next time: 2
patients because of difficult side effects, PONV and dizziness, 2 would like to
communicate with the surgeon during the operation, and 2 would like to try
spinal anaesthesia. No one complained of insufficient pain relief in the GA group.
In the SSA group, the one patient with PDPH would like to try general anaesthe-
sia in the future.
Table 11. Patient satisfaction.
I II III IV V
B4 B6 B3F B4 O4 O8 P L2/3 L3/4T L3/4H SSA GA
Patients’
experience
superior 34(72) 31(62) 35(73) 43(88) 22(79) 22(82) 27(90) 30 (83) 34 (87) 27(77) 26(90) 23(74)
equal 11(23) 15(30) 10(21) 6 (12) 3 (11) 2 (7) 3 (10) 4 (11) 4 (10) 7 (20) 3 (10) 7 (23)
worse than 2 (4) 4 (8) 3 (6) 0 3 (11) 3 (11) 0 2 (6) 1 (3) 1(3) 0 1 (3)
anticipated
Willingness to
have same
anaesthesia
yes 46(98) 47 (94) 47 (98) 48(98) 26(93) 24(92) 30(100) 36(100) 39(100) 34(97) 28(97) 25(81)
no 1 (2) 3 (6) 1 (2) 1 (2) 2 (7) 2 (8) 0 0 0 1 (3) 1 (3) 6 (19)
Values are n (%).
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Discussion
Methodology
Sensory and sacral segment block
In all five studies, the level of sensory and sacral segment block was assessed by
using thermal stimuli, i.e. a cold acetone drop. Methods such as the loss of sharp
pinprick, the loss of cold and the loss of touch sensations are used to test the level
of sensory block. Some studies with lidocaine and bupivacaine and fentanyl showed
that during spinal anaesthesia, the levels of analgesia (pinprick) and cold sensa-
tion were equal (White et al. 1998; Patterson et al. 2001). Furthermore, the level
of anaesthesia was 3 dermatomes lower (caudad) than the levels of analgesia and
cold sensation (White et al. 1998). Earlier Brull and Green found that the loss of
sensation to pinprick is 2 dermatomes cephalad compared to loss of touch, after
i.t. hyperbaric bupivacaine (Brull and Greene 1989). In studies with patients
undergoing caesarean section, loss of both cold and pinprick sensations have
poorly predicted the level of adequate anaesthesia (Alahuhta et al. 1990; Hiraba-
yashi et al. 1995a), whereas in a recent study it was found that loss of touch
would predict better the level of anaesthesia in these patients (Russell 2004), a
result demonstrated already much earlier with surgical patients (Rocco et al. 1985).
On the other hand, Liu and Ware (1997) concluded in their study with volun-
teers, that after spinal anaesthesia with hyperbaric bupivacaine, the sensory block
either to touch, pinprick or cold was a poor predictor for surgical anaesthesia and
tourniquet pain. They used tolerance to transcutaneous electrical stimulation (TES)
with an intensity of stimulation equivalent to surgical incision. However, the loss
of cold sensation tested with a cold acetone drop is an easy and cheap method.
Together with adequately tested motor block, they brought acceptable informa-
tion of surgical anaesthesia in patients undergoing knee arthroscopy.
The sacral segment (S1) block was evaluated by using cold stimulus, too. The
dermatome S1 was tested separately on both sides; this gave only a rough esti-
mate of the true sacral block (the dermatomes S2-S4 where not tested). Together
with an absence of motor block at the myotome S1 (= ankle plantar flexion), the
lack of sacral block was more evident.
Motor block
The motor block was assessed by using a modified Bromage scale, where 5 myo-
tomes (L2-S1) corresponding to a specific joint movement were tested separately
on both sides (0= no block of a myotome and 1=myotome blocked) (Kuusniemi
et al. 1997; Kuusniemi et al. 1999; Kuusniemi et al. 2000a). Although most
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studies have used a Bromage scale from 0 to 3 (0= no motor block, 1=hip blocked,
2=hip and knee blocked, 3=hip, knee and foot blocked), we wanted to have a
method, in which the 5 myotomes could be tested independently. This provided
us with a possibility to estimate whether the site of injection or the posture of the
vertebral column had an effect on motor block, by moving the blocked myotome
cephalad (Study IV). Being simple to perform and easy for the patient, without
special equipment, the modified Bromage scale offers a reliable method to test
the onset and quality of motor block for the surgical procedure.
However, when evaluating the recovery from motor block, other methods
than the Bromage scale might be more suitable. A quantitative method measur-
ing isometric muscle strength showed that the actual recovery of motor strength
after a high dose of bupivacaine was reached 1.5–2 h later than estimated when
using the Bromage scale (Axelsson et al. 1985). The standard clinical tests of
motor recovery were found to be poor predictors of functional balance after low-
dose i.t. bupivacaine and fentanyl. Although 100% of the patients had regained
gross motor functions (Bromage scale, joint position, leg raising, deep knee bend-
ing and heel-to-shin touch) 60 min after spinal injection, only 36% of the pa-
tients could stand, and 8% of the patients could walk without assistance at that
time (P < 0.01). The majority, 96% of the patients, could walk adequately 150
min after spinal injection (Imarengiaye et al. 2003). Although the spinal block
was bilateral in their study, and accordingly the disturbances of motor function,
balance and postural stability were bilateral, a similar walking lag was observed in
our studies: 96% of the patients after i.t. bupivacaine 3 mg + fentanyl 10 µg and
83% of the patients after i.t. bupivacaine 4 mg had recovered from motor block
(assessed by a modified Bromage scale) 120 min after spinal block, but the ability
to walk followed 30-40 min later (Studies I-III). As Imarengiaye and co-workers
concluded, ambulation without assistance should be a major factor when deter-
mining home-readiness in outpatients (Imarengiaye et al. 2003).
The anaesthetic techniques used in spinal anaesthesia and general
anaesthesia
The discharge time is used to estimate the efficacy of different anaesthesia tech-
niques. Furthermore, fast-tracking results in a shorter stay in the postanaesthesia
care unit (PACU) and thus, might save costs as a result of the decreased need of
personnel in PACU (Marshall and Chung 1999). In Study V, focussing on the
efficacy of selective spinal anaesthesia and general anaesthesia, the GA was main-
tained with desflurane, because earlier studies have shown the better fast-tracking
eligibility after desflurane compared to sevoflurane and propofol (Song et al.
1998). Tracheal intubation was chosen instead of LMA, because in the study
hospital the surgeons who performed the knee arthroscopies were mainly resi-
dents, and thus motor relaxation was required. Since the surgeon had considered
the relaxation to be poor in 4% of the patients after the 4 mg dose and in up to
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16% of the patients after the i.t. combination of 3 mg bupivacaine and 10 µg
fentanyl (Studies II-III), we preferred to use the 4 mg dose in the SSA group and
neuromuscular blocking agents in the GA group. To minimize the need for reversal
drugs, a low-dose rocuronium was used with careful monitoring of muscle relaxa-
tion (adductor pollicis TOF ratio by using kinemyographic measurement with
Datex-Ohmeda MechanoSensor®) in the GA group. The use of LMA instead of
tracheal intubation could have shortened the time to extubation and orientation in
the GA group. Whether the use of LMA would have influenced fast-tracking or
home-readiness is more difficult to estimate: the factors which hindered the PACU
bypass were pain, dizziness, sedation and shivering. However, it is possible that the
use of tracheal intubation might have caused a bias in favour of SSA versus GA.
The risk for postoperative nausea and vomiting (PONV) was assessed before
general anaesthesia (Apfel et al. 1999), and the patients with ≥2 risk factors
(female, non-smoker, history of PONV or motion sickness) received double proph-
ylaxis. This concept has been suggested also in a recent multicenter study, al-
though the most preferable/cost-effective combination for preventing PONV
would be dexamethason and droperidol (Apfel et al. 2004). However, droperi-
dol may cause delayed recovery (Valanne and Korttila 1985), which is why we
used dexamethason and ondansetron.
Study design
All studies were prospective, randomized clinical trials, and the size of each study
group was based on power analysis. Studies I-IV were double-blinded, whereas
in Study V the different nature of the anaesthesia techniques made the blinding
of the study impossible, which may have biased the results.
Assessment of recovery and home-discharge criteria
When Study I was conducted (in 2000), fast-tracking was not used for outpa-
tients undergoing neuraxial anaesthesia in the study hospital. The highest prob-
ability of PACU bypass was seen after the combination of bupivacaine and fenta-
nyl (35% of the patients (47/133), Studies II-III) because of the shortest time to
gross motor recovery. The protocol in the present studies to follow the patients
in the PACU until complete motor recovery (Bromage), sensory block not above
Th12 and vital signs resulted in only 12% (23/199) of the patients to be able to
bypass PACU after 4 mg of bupivacaine (Studies II, IV, V). However, the ability
to move the lower extremities fully is not required before discharge from PACU
in the various PACU bypass criteria (Aldrete 1995; White and Song 1999).
In most studies, a modified Aldrete scoring (Appendix 1) system has been
used when determining the possibility of fast-tracking, after either GA or SA.
Since in these criteria pain and PONV are not included, White and Song devel-
oped a more suitable scoring system for PACU bypassing (Appendix 2) and found
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that a higher percentage of the patients having been judged eligible for fast-
tracking using a modified Alderete scoring system required more i.v. analgesics
and antiemetics compared with assessing the ability of bypassing PACU by using
the new criteria (White and Song 1999). The new criteria were, however, de-
signed for outpatients undergoing general anaesthesia, not neuraxial anaesthesia.
Furthermore, the level of sensory block has not been taken into account, which
may increase the possibility of orthostasis when the patient rises to a sitting posi-
tion. In Study V, the PACU discharge was evaluated by using both the new fast-
tracking scoring system (all patients), and furthermore, complete recovery from
motor block and sensory block not above Th12 (the patients undergoing spinal
anaesthesia). In the spinal group, the PACU bypass was possible, if the later
criteria were fulfilled at the end of surgery, but the fulfilment of the new fast-
tracking criteria were recorded as well. In both groups, the patient had to be able
to sit up (without any symptoms like dizziness, nausea) before being transferred
to ASU. The different criteria used in Study V between SSA and GA, as well as in
the literature between different methods, make the estimation of the fast-track-
ing possibility after a particular anaesthesia method difficult. In future, when
comparing general and neuraxial anaesthesia, the PACU bypass criteria presented
by Williams and co-workers might be the most useful, since they include also
pain, PONV, shivering and orthostasis (Williams et al. 2000; Williams et al. 2002;
Williams 2004; Williams et al. 2004) (Appendix 4). Their studies, however, were
observational and retrospective.
In Studies I-IV, the home discharge criteria consisted of absence of PONV,
no or minimal pain, no bleeding, and ability to walk and void. In Study V, the
ability to void was no longer required, but the time to urinate was recorded, if
the patient still remained in hospital (the escort arrived late).
Spinal anaesthesia
Spinal anaesthesia technique
The aim of the studies was to develop a selective spinal anaesthesia for ambulato-
ry knee arthroscopy. Ideally, the SSA would be unilateral, with only minimal or
no motor block left at the end of the operation. The sensory block of dermatomes
L1-L5 would be essential. If the S1 dermatome is not blocked, some patients
may sense discomfort from the tourniquet at the backside of their thigh. On the
other hand, if the pelvic nerves (S2 – S4) are not blocked, the ability to void after
spinal anaesthesia may be facilitated (Kamphuis et al. 1998).
In all the present studies, the basic elements of the injection technique were
equal: low-dose (3–6 mg of bupivacaine), low-volume (0.8–1.2 ml) and mini-
mal-flow (0.4–0.6 ml/min), the use of hyperbaric solution, and maintenance of
the lateral decubitus position for 10 min. The horizontal posture (or the 5 de-
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gree head down tilt of the vertebral column in one group in Study IV) of the
vertebral column was ensured with the help of a spirit level in Studies II-V. When
the table is horizontal, the position of the vertebral column of a laterally placed
patient is usually tilted between –5 and +5 degrees depending on the build of the
patient: in women the broad pelvis can cause a slight head-down position of the
vertebral column already when lying sideways, and in men with wide shoulders
the opposite is true. Hence, the posture of the vertebral column needs to be
measured in order to have an exact spread of hyperbaric local anaesthetic. Fur-
thermore, the L2/3 vertebral interspace was used in all studies, except in Study
IV, where the L3/4 interspace was used in two out of three groups. The dural
puncture was made with a Quincke type needle (G27) in all studies.
Although the spread of spinal anaesthesia has been claimed to be unpredict-
able (Connolly and Wildsmith 1998), an identical spread of sensory block was
demonstrated in different studies (I-III) when the same dose of bupivacaine or
the combination was used (Figure 1). Also the gross motor recovery was almost
equal after the same dose (Figure 4). We believe that a strictly standardized injec-
tion technique together with a low dose of hyperbaric bupivacaine resulted in
this predictable spread of SA. Furthermore, a significantly higher spread of spinal
block was found after a 6 mg dose of i.t. bupivacaine compared to a 4 mg dose,
when the L2/3 interspace was used, but if the 4 mg dose was injected at L3/4
interspace and the posture of the vertebral column was tilted 5 degrees head
down at the same time, a similar upper dermatomal spread was seen as after the 6
mg dose at L2/3 interspace. The combination of 3 mg of bupivacaine and 10 µg
of fentanyl injected at L2/3 interspace resulted in an equally low spread as the
injection of 4 mg of bupivacaine at L3/4 interspace without the tilt, but the
latter method resulted in too many failures (12%), whereas 3.5% of the blocks
failed overall. Although the difference in the failure rate was not statistically sig-
nificant, the trend towards a higher risk of failure is clinically important.
There are some points to be criticized with respect to the technique. First, the
L2/3 vertebral interspace was mainly used. Broadbent and co-workers (2000)
demonstrated a poor capability of anaesthetists to identify the actual vertebral
interspace: only 29% of the anaesthesiologists in their study could identify the
interspace correctly. More recently, in a study with cadavers, a higher percentage
of the anaesthetists (49%) were able to identify the interspace correctly at the Th8
– L4 region. Unfortunately, this study confirmed the tendency of anaesthetists to
estimate the interspace to be more caudal than it actually was (Lirk et al. 2004).
One can assume that the risk to insert the needle at the L1/2 interspace (and thus
possibly damage the conus) is higher, if the intended interspace is L2/3 rather
than L3/4. On the other hand, the L2/3 interspace is widely used in both con-
ventional and unilateral spinal anaesthesia techniques, and it is recommended in
a fresh textbook of regional anaesthesia: “The L2/3 interspace is usually pre-
ferred because injection at this level will take maximum advantage of the lumbar
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spinal curvature to encourage spread of the solution both cephalad and caudad”
(Mulroy 2002b). Furthermore, in Study IV, the possibility of choosing the in-
tented interspace incorrectly may have influenced the spread of the block and
thus lowered the accuracy of the results.
Second, the injections were made with a 27-G Quincke needle (Becton-Dick-
inson Yale Spinal), not with a pencil-point needle. The Quincke needle is associ-
ated with higher risk of PDPH than a pencil-point needle (Santanen et al. 2004).
Furthermore, Tanasichuk demonstrated a long time ago that the pencil-point
needle resulted in more patients having spinal hemianalgesia compared with the
use of a Pitkin needle (Tanasichuk et al. 1961). Later, Casati et al. achieved a
more marked differential sensory block with a Whitacre spinal needle compared
to a Quincke needle (Casati et al. 1998a). In future, a good practice would be to
use a pencil-point needle at the L3/4 lumbar interspace with the vertebral col-
umn tilted 5 degrees head down for the first 6 min.
Selective spinal anaesthesia
Highly unilateral motor block (87-100% of the patients) and sacral segment (both
dermatome and myotome S1) (61-90%) block were found in all studies, whereas
sensory block was only moderately unilateral. Interestingly, in some patients the
S1 dermatome remained unblocked on the dependent side (Table 7), and the
myotome S1 was unaffected at the operative side in 73%, 80% and 66% of the
patients in Studies II, III, IV. The sensory sacral segment (S1) was significantly
less affected when injected at L3/4 level with a head down tilt compared to
injection at the same site with horizontal position (Figure 3). Traditionally, spi-
nal anaesthesia has been considered to “produce total neural blockade caudad to
the site of injection” (Mulroy 2002b). We nevertheless found a spinal block re-
sembling more or less a segmental epidural block, in some of the patients.
Reliability of spinal anaesthesia
In our studies, the overall incidence of failure was 4.3% after SSA (all groups),
which is in accordance with both earlier findings with low-dose / unilateral spi-
nal anaesthesia 0-6% (Pittoni et al. 1995; Fanelli et al. 2000; Kuusniemi et al.
2000a; Kaya et al. 2004), and with conventional spinal anaesthesia 1-3.1% (Tark-
kila 1991; Puolakka et al. 2000). The overall incidence of failure diminishes to
3.5 % (14 patients out of 401), if the L3/4 horizontal group (Study IV), with an
unacceptably high failure rate (12%) is excluded. In Table 12, the results from
Studies I-III of the thesis are combined, and these results as well as the results
from Study IV are compared to recent clinical trials of low-dose/unilateral spinal
anaesthesia techniques.
A lighter motor block was achieved when using the combination of 3 mg of
bupivacaine and 10 µg of fentanyl versus 4 mg of bupivacaine (Study II) and thus,
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Table 12. A comparison of different low-dose/ unilateral spinal anaesthesia techniques used in outpatients undergoing knee
arthroscopy. The results from recent prospective, randomized clinical trials, as well as from studies I-IV of the thesis.
Reference No. Anaesthetic Lateral  Failure Preparation Time to Comments/Other
technique decubitus (%) time discharge results
(min) (min, h)
(Kaya et al. 50 7.5 mg bupivacaine 15 0 NA NA 68% vs. 24% of the
2004) hyperbaric patients had unilateral
hypobaric sensory block after
hyperbaric and
hypobaric bupivacaine
(P<0.05).
(Borghi 90 hyperbaric bupivacaine 15 0 NA Unilateral block in 90,
et al. 2003) 4 mg ~ 100 93 and 77% of the
6 mg ~ 150 patients in the groups
8 mg ~ 160 of 4, 6 and 8 mg.
P<0.05 Walking with crutches was
required, but not voiding.
(Fanelli et al. 100 8 mg hyperbaric Voiding was required.
2000) bupivacaine Need for vasopressors
unilateral 15 6 16 [15-30] 264 ± 95 was higher in
conventional 0 6 13 [5-25] 281 ± 83 conventional group:
P=0.0005 NS 11% vs. 0% of the
patients (P = 0.02).
(Kuusniemi 60 6 mg of bupivacaine 20 0 NA Unilateral motor and
et al. 2000a) plain 0.5 % 4.9 ± 0.8 sensory blocks were
hyperbaric 0.5 % 4.8 ± 1.0 found in 37% vs. 83%
of the patients (P<0.01)
after plain and hyperbaric
i.t. bupivacaine.
(Casati et al. 30 8 mg hyperbaric 15 NA NA 66% vs 13% of the
1998a) bupivacaine patients had unilateral
25G Whitacre needle 7¹ sensory block in
25G Quincke needle 7 Whitacre and Quincke
groups (P<0.05).
(Ben-David 50 Diluted 0.17 % NA Voiding was required
et al. 1997) bupivacaine 5 mg 0 24 187 ± 51 before discharge
5 mg + 10 µg 0 0 195 ± 49
fentanyl P<0.05 NS
(Ben-David 110 1 % hypobaric NA Voiding was required.
et al. 2000) lidocaine 50mg 0 0 180 ± 31 TNS in 33 vs. 4% of the
lidocaine 20mg + 0 0 145 ± 38 patients, in the lidocaine
fentanyl 25µg vs. combination group.
P=0.002 (P<0.0001).
(Valanne 291 Hyperbaric 10 NA Voiding was required.
et al. 2001, bupivacaine Shorter time in PACU
Korhonen 3 mg + fentanyl 10 µg 4 178 ± 39 after the combination
et al. 2003) 4 mg 3 186 ± 39* than after 4 mg dose,
Studies I-III 6 mg 2 218 ± 41* but 75% developed
*P<0.001 pruritus after i.t. fentantyl.
(Korhonen 119 Hyperbaric 10 NA A more segmental
 et al. 2004 bupivacaine nature of the block,
Study IV) 4 mg when L3/4 was used
L2/3 horizontal 5 213 ± 41 with a head down tilt for
L3/4 tilt 2.5 198 ± 33 6 min compared to a
L3/4 horizontal 12 195 ± 30 horizontal position
Time values (min, h) are either median [range] or mean ± SD, ¹The one patient in the Whitacre group needed no GA, but
needed additional analgesia and sedation 60 min after dural puncture.
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faster gross motor recovery. In this study, the quality of motor block assessed by a
surgeon was considered mostly “good” in both groups, whereas in Study III, the
quality of motor block was judged to be “poor” in 16% of the patients.
The overall need for additional opioids during surgery after SSA was 12%
(51/423), which is in accordance with earlier studies with low-dose unilateral SA
(Kuusniemi et al. 1997; Kuusniemi et al. 1999; Kuusniemi et al. 2000b; Kuus-
niemi et al. 2001).
As low a dose as 3 mg of bupivacaine together with fentanyl 10 µg or 4 mg of
bupivacaine alone provided an equally reliable block for knee arthroscopy, a find-
ing confirmed in a recent study (Kiran and Upma 2004). The combination did
not, however, offer benefits over a 4 mg dose, because 75% of the patients in the
fentanyl group developed pruritus and no earlier fulfilment of home discharge
criteria. On the other hand, a significant reduction in the failure rate was found
when 10–12.5 µg of fentanyl was combined with 5 mg of bupivacaine (Ben-
David et al. 1997; Goel et al. 2003). Perhaps the high failure rate (12%) after i.t.
injection of 4 mg of bupivacaine at the L3/4 interspace without a head down tilt
(Study IV) might have been reduced by combining a low dose i.t. fentanyl.
Side effects after selective spinal anaesthesia
Cardiovascular
Low-dose spinal anaesthesia causes less hypotension than SA induced with a con-
ventional dose, 4% (Kuusniemi et al. 1997; Kuusniemi et al. 1999; Kuusniemi et
al. 2000a; Kuusniemi et al. 2001) versus 33% (Carpenter et al. 1992), respective-
ly. In our studies, the overall incidence of hypotension was low: 3%, whereas the
number of patients needing treatment for bradycardia 44/423 (11%) is equal to
the number after a conventional dose, 9-13% (Tarkkila and Kaukinen 1991; Car-
penter et al. 1992). Young age (Tarkkila and Kaukinen 1991), as well as the ASA
physical status I (Liu and McDonald 2001) have been found to correlate with
bradycardia following spinal anaesthesia, which might explain the high frequen-
cy of bradycardia in our material. The discomfort due to a noxious stimulus
during surgery may cause a vasovagal reaction, but is an unlikely explanation in
the present studies, because only 5 (11%) of the patients who received medication
for bradycardia needed additional opioids.
Transient neurological symptoms (TNS), postdural puncture headache
(PDPH) and backache
The overall incidence of TNS was 3% after SSA with low-dose bupivacaine or the
combination of bupivacaine and fentanyl, which is in accordance with earlier
studies (Hiller and Rosenberg 1997; Kuusniemi et al. 1997; Keld et al. 2000;
Kuusniemi et al. 2000a). Hiller and co-workers (1999) raported TNS after GA,
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which was confirmed in Study V: two patients (6%) in the GA group fulfilled our
TNS criteria, which supports the hypothesis of the musculoskeletal origin of
these symptoms (Rowlingson 2000; Faccenda and Finucane 2001) and the find-
ing that patients undergoing knee arthroscopy are at risk of developing TNS
(Pollock 2003). Five percent of the patients suffered from PDPH. Today, the
incidence of PDPH is shown to be less than 3%, when pencil-point needles are
used. The percentage of PDPH could probably be diminished by changing the
Quincke needle to a pencil-point needle (Santanen et al. 2004). Twelve percent
of the SSA patients had non-radiating backache, which is comparable with earlier
studies (Hiller et al. 1999; Faccenda and Finucane 2001).
Difficulties in voiding
Dysuria at home was reported by a few patients after all doses of i.t. bupivacaine
(alone or together with fentanyl) and after GA, but none of the patients needed
catheterization. This, together with the finding of unilateral sacral block sup-
ports the idea of home readiness without voiding requirements after knee ar-
throscopy when short-acting agents or bupivacaine less than 7 mg are used (Mul-
roy et al. 2002). We agree that the high-risk patients should urinate before home
discharge and, furthermore, attention should be paid particularly with increasing
doses of bupivacaine. The prolonged detrusor block (462 min) after 10 mg of i.t.
bupivacaine (Kamphuis et al. 1998), speaks against a 10 mg dose of bupivacaine
in day-surgery. The 8 mg dose has been used in either conventional or unilateral
spinal anaesthesia for knee arthroscopy, with a home-discharge time of 4 to 4.5
hours (voiding required) (Casati et al. 1998b; Fanelli et al. 2000). Using a con-
ventional technique in volunteers, Liu and co-workers demonstrated that every
additional mg of bupivacaine delays home-readiness by 21 min (Liu et al. 1996).
Although the delay per mg with unilateral/selective spinal technique may differ
(the restricted block prolongs recovery, on the other hand, the one-sided sacral
segment block can facilitate the ability to void), the importance of reducing the
dose becomes clear.
Pruritus
Pruritus was a common side effect after mini-dose i.t. fentanyl. In earlier studies,
ondansetron could partly prevent pruritus induced by i.t. morphine (Yeh et al.
2000) and by higher dose of i.t. fentanyl (Gürkan and Toker 2002). We, howev-
er, found no difference in the incidence of pruritus, when prophylactic ondanset-
ron was compared to placebo. It is possible, that the mild and short-acting pru-
ritus induced by low-dose fentanyl (10 µg) in our study, made the evaluation of
the level of the pruritus more difficult. A similar result, however, was found in a
recent study with prophylactic ondansetron and i.t. sufentanil (10 µg) (Waxler et
al. 2004).
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Spinal anaesthesia in ambulatory surgery
The time to home-readiness in the present studies is compared with the results of
other clinical trials in Table 12. The different subgroups (bupivacaine 3 mg and
fentanyl 10 µg, bupivacaine 4 mg and 6 mg) in Studies I-III are combined in this
table. The time to home-readiness after 3 mg of bupivacaine and 10 µg of fenta-
nyl or 4 mg of bupivacaine is comparable to the home discharge time after 50 mg
of lidocaine or after 5 mg of bupivacaine in the studies of Ben-David and co-
workers (Ben-David et al. 1997; Ben-David et al. 2000). They were able to reduce
the time to home readiness significantly when combining 20 mg of lidocaine and
25 µg of fentanyl (Ben-David et al. 2000). With equal doses of hyperbaric bupi-
vacaine (4, 6 or 8 mg), the fulfilment of home discharge criteria were gained
significantly earlier than in our studies. However, the authors concluded that the
different home-discharge criteria might be the explanation (walking with crutch-
es instead of without assistance), between their and our studies (Borghi et al.
2003).
In Study IV, the time to home-readiness was longer in all groups, than in our
other studies. Since this time was prolonged by 30 min also in the control group
(L2/3 group), reasons other than related to the spinal technique were consid-
ered, too. It appeared that when Study IV was conducted, the overall number of
ambulatory patients had rapidly grown, while there was a temporary shortage of
personnel (only one physiotherapist) in the ASU. This might have influenced the
time to home readiness.
Selective spinal anaesthesia versus general
anaesthesia in outpatients
In Study V, the possibility of PACU bypass and the times in the PACU and until
home readiness were similar after both SSA with 4 mg of bupivacaine and GA
maintained with desflurane. A significantly higher number of patients suffered
from side effects such as pain, somnolence and PONV (despite the double proph-
ylaxis) and needed more postoperative opioids after desflurane-maintained GA
than after SSA, whereas PDPH and backache were seen more after SSA. On the
other hand, an intra-articular local anaesthetic together with morphine might
have been beneficial in lowering the pain scores in the GA group (Kalso et al.
2002), and further in reducing the risk of PONV. Perhaps a higher percentage of
the patients in the GA group could also have been fast-tracked, if this method
had been included in the study protocol. In a study where locally and IA bupi-
vacaine was administered by a surgeon (Jankowski et al. 2003), 35% of the pa-
tients after GA (propofol infusion, NO2, LMA) could bypass PACU compared to
our 22%. In Study V, similar home discharge times were seen between the SSA
and GA groups, being comparable with the results of Jankowski and co-workers.
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After SSA for gynaecological laparoscopy (10 mg of lidocaine and 10 µg of suf-
entanil), the patients could ambulate 3 min after surgery, but their time to dis-
charge after the end of surgery, 112 min (Lennox et al. 2002b), is comparable
with our 114 min (Study V).
The overall anaesthesia-related time (ART) was 1.5 min longer in the SSA
than in the GA group (V). Although the difference was statistically significant,
such a short time has no clinical relevance. In the SSA group, the ART consisted
only of the preparation time (17 min), because all the patients were awake and
orientated at the time of tourniquet release. A similar preparation time (16 min)
was demonstrated after unilateral spinal anaesthesia with 8 mg of hyperbaric bupi-
vacaine, and readiness for surgery required 13 min after conventional bilateral
block (Fanelli et al. 2000). In the SSA group, a 17 min reduction in the OR time
could have been achieved, if an induction room had been used. However, this
imposes other costs and requirements in terms of both physical plant and person-
nel. On the other hand, had we used the LMA and spontaneous ventilation in
the GA group, a reduction in anaesthesia-related time in the OR might have
been achieved in the GA group, too. When the GA patients in Study V were
extubated and orientated 7.5 min after the release of the tourniquet, in other
studies 3.4 – 4 min time to orientation was noted after GA maintained with
desflurane and LMA (Tang et al. 2001; Dolk et al. 2002).
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Conclusions
The following conclusions can be drawn from the present studies:
1. All study doses of hyberbaric bupivacaine (3 mg of bupivacaine together with
10 µg of fentanyl, 4 mg or 6 mg of bupivacaine) injected at the L2/3 inter-
space produced a reliable SSA, with readiness to discharge home suitable for
ambulatory knee arthroscopy. However, a significantly shorter time to home
readiness was achieved when using either the combination of bupivacaine and
fentanyl (3 mg+10 µg) or 4 mg of bupivacaine compared to the 6 mg dose.
Time to home-readiness was similar after SSA with 4 mg of bupivacaine and
GA maintained with desflurane.
2. Although the faster recovery of gross motor functions resulted in better fast-
tracking possibilities after spinal injection of 3 mg bupivacaine + 10 µg fen-
tanyl compared to the 4 mg dose of bupivacaine, no earlier discharge home
was found. No difference in PACU bypass rate was seen between the SSA and
GA groups.
3. A strictly standardised spinal anaesthesia technique including the use of a
spirit level to ensure the desired position of the vertebral column resulted in
a predictable spread of spinal block with the same dose of hyperbaric bupi-
vacaine injected at L2/3 interspace. When using a L3/4 interspace for injec-
tion, a measured head down tilt of the vertebral column moved the blocked
dermatomes and myotomes cephalad thus producing a true segmental block.
A trend towards an increased risk of failure was seen in patients injected at
L3/4 interspace with the vertebral column horizontal at the time of injec-
tion.
4. Postoperatively, nausea and vomiting, pain and somnolence were more fre-
quent after general than after spinal anaesthesia, whereas the risk of postdural
puncture headache was quite high after spinal anaesthesia when a 27-G
Quincke needle was used. Pruritus was a common side effect after i.t. fenta-
nyl, and ondansetron 4 or 8 mg i.v. could not prevent it. The low incidence
of transient neurological symptoms was similar to earlier studies with bupi-
vacaine and TNS occurred equally after SSA and GA. A higher number of
SSA patients had backache compared to GA patients. Only a few patients,
after both SSA (all doses) and GA, developed minor difficulties in voiding,
but no one needed catheterization.
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Clinical Considerations
Selective spinal anaesthesia with a 4 mg dose of hyperbaric bupivacaine produces
reliable anaesthesia for knee arthroscopy with tourniquet lasting up to 80-100
min, with a home readiness 3 hours after the spinal injection.
Maintenance of the lateral decubitus position for 10 min is sufficient to restrict
the spread of the selective spinal anaesthesia with hyperbaric bupivacaine.
Also residents with limited experience in spinal anaesthesia may administer selec-
tive spinal anaesthesia. However, knowledge of the selective spinal technique and
a thorough understanding of the factors affecting the spread of spinal block are
essential.
Although the failure rate after SSA in the present studies is similar to that after a
conventional dose of spinal anaesthetic: 3.5% versus 1-3.1%, respectively, one
should aim at 100% success. Adjusting the position of the vertebral column care-
fully – horizontal if injecting at L2/3 interspace or tilting 5 degrees head down
if injecting at the L3/4 interspace – diminishes the risk of failure, which may be
further decreased by using a combination of i.t. bupivacaine 4 mg and fentanyl
10 µg, but then, 75% of the patients would develop mild pruritus.
To avoid the high risk of postdural puncture headache it might be reasonable to
choose another type of needle instead of the G-27 Quincke needle used in these
studies. The use of L3/4 interspace with a 5 degree head down tilt of the verte-
bral column is recommended for increased neurological safety.
For the patients not suitable for neuraxial anaesthesia, desflurane-maintained general
anaesthesia provides equally fast home-readiness as SSA with 4 mg of bupivacaine,
after knee arthroscopy. Backache was more frequent after SSA, but the incidence
of TNS was similar after both methods. On the other hand, higher pain VAS
scores, greater need for postoperative opioids, more PONV and somnolence were
observed in the patients undergoing general anaesthesia. However, adding intra-
articular local anaesthetic and/or morphine to their treatment would probably
decrease the pain, the need for opioids, and thus PONV, as well.
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Appendices
Appendix 1
Postanesthesia Recovery Score (Modified Aldrete Score)
Consciousness Circulation
Fully awake and orientated (name, place, date) 2 Blood pressure ± 20% of preanaesthetic level 2
Arousable on calling 1 Blood pressure ± 20-49% of preanaesthetic level 1
Not responding 0 Blood pressure ± 50% of preanaesthetic level 0
Activity Oxygen saturation
Moves all 4 extremities voluntarily or on 2 SpO2 >92% on room air 2
command
Moves two extremities voluntarily or on command 1 Supplemental required to maintain SpO2 >90% 1
Unable to move extremities 0 SpO2 <90% with supplementation 0
Respiration
Breathes deeply and coughs freely 2
Dyspnoea, limited breathing, or tachypnea 1
Apneic or on mechanical ventilation 0 Maximum score 1 0
(Aldrete and Kroulik 1970; Aldrete 1995)
Appendix 2
The New Fast-Tracking Criteria
Level of consciousness score Oxygen saturation status
Awake and oriented 2 Maintains value >90% on room air 2
Arousable with minimal stimulation 1 Requires supplemental oxygen (nasal prongs) 1
Responsive only to tactile stimulation 0 Saturation <90% with supplemental oxygen 0
Physical activity Postoperative pain assessment
Able to move all extremities on command 2 None or mild discomfort 2
Some weakness in movement of extremities 1 Moderate to severe pain controlled with IV analgesics 1
Unable to voluntarily move extremities 0 Persistent severe pain 0
Haemodynamic stability Postoperative emetic symptoms
NIBP decreased <15% of baseline MAP 2 None or mild nausea with no active vomiting 2
NIBP decreased 15%–30% of baseline MAP 1 Transient vomiting or retching 1
NIBP decreased >30% below baseline MAP 0 Persistent moderate to severe nausea and vomiting 0
Respiratory stability
Able to breathe deeply 2
Tachypnoea with good cough 1 Total Score 1 4
Dyspneic with weak cough 0 A minimum score of 12 (with no zeros) is
required to bypass PACU
(White and Song 1999)
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Appendix 3
Post Anaesthetic Discharge Scoring System (PADS)
Vital signes Surgical bleeding
Within 20% of preoperative value 2 Minimal 2
20-40% of preoperative value 1 Moderate 1
> 40% of preoperative value 0 Severe 0
Activity and mental status Intake and output
Oriented × 3 AND has a steady gait 2 Has had p.o. fluids AND voided 2
Oriented × 3 OR has a steady gait 1 Has had p.o. fluids OR voided 1
Neither 0 Neither 0
Pain, nausea and/or vomiting
Minimal 2
Moderate 1 Total PADS score 1 0
Severe 0 Considered fit for discharge ≥9
(Chung et al. 1995)
Appendix 4
A Post-Anaesthetic Discharge Scoring System
Movement Respiratory effort
Purposeful movement of (at least) one lower and 2 Coughs and deep breathes freely, and/or on command 2
one upper extremity
Purposeful movement of at least one upper but 1 Able to cough involuntarily, not on command, 1
neither lower extremity  maintains airway without support
No purposeful movement 0 Tachypnoea, dyspnoea, or apnoea, and/or
requiring maintenance 0
Blood pressure (Sitting position assessment Pulse oximetry score
required after a supine assessement)
Within 20% of preoperative baseline, without 2 SpO2 ≥95% on room air 2
orthostatic changes
Between 20-40% of preoperative baseline, 1 SpO2 ≥95% with face mask or nasal cannula 1
without orthostatic changes
Less than 40% of preoperative baseline, and/or 0 SpO2 <95% 0
orthostatic changes
Level of consciousness
Awake, follows commands, easily aroused when 2
called
Arousable to stimuli, with protective reflexes, 1 Total score 1 0
with/without following commands
Obtunded or persistently somnolent, with or without 0 The minimum score to qualify for PACU bypass 8
protective reflexes
Patients considered for PACU bypass should not require interventions for pain, postoperative nausea
and vomiting, or shivering. Patient pain scores should not exceed 2-3 (out of 10) at the time of PACU
bypass or PACU discharge. (Williams et al. 2004)
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